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Abstract 
Factors Associated with Hospital Readmissions Among United States Dialysis Facilities 
By Amber Brooke Paulus, Ph.D. 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy in Nursing at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2019 
 
Major Director: Marianne Baernholdt, PhD, MPH, RN, FAAN, 
Nursing Alumni Endowed Professor, School of Nursing 
 
Hospital readmissions are a major burden for patients with end stage renal disease 
(ESRD). On average, one in three hospital discharges among patients with ESRD are 
followed by a readmission within 30 days. Currently, dialysis facilities are held 
accountable for readmissions via the ESRD Quality Incentive Program standardized 
readmission ratio (SRR) clinical measure. However, little is known about facility-level 
factors associated with readmission. Additionally, unlike other standardized measures of 
quality in the dialysis setting, incident patients within their first 90-days of dialysis are 
included in the performance calculation. This study analyzed CMS Dialysis Facility 
Report data from 2013 to 2016 to examine dialysis facility and incident patient factors 
associated with SRR using multivariate mixed models. Among 5,419 dialysis facilities 
treating 104,768 incident patients, the mean SRR remained stable across all four study 
years at 0.99. Factors significantly associated with a lower SRR (p<0.0001) included 
Western geographic region and higher patient care technician ratios. Several incident 
patient pre-dialysis nephrology care characteristics were associated with lower SRRs 
including higher percentages of patients with a fistula present at first dialysis treatment, 
higher percentages of patients receiving 6-12 months or greater than 12 months of 
 
 
 8 
nephrology care prior to dialysis and higher facility average hemoglobin. Factors 
significantly associated with a higher SRR (p<0.0001) included Northeastern geographic 
region, higher registered nurse ratios, higher percentage of incident patients, and higher 
facility average GFR. Understanding facility-level and patient-level factors associated 
with higher SRRs may inform interventions to reduce 30-day hospital readmission 
among patients receiving dialysis. 
 
Keywords: Dialysis facilities, hospital readmissions, incident patients, ESRD 
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Introduction 
As a requirement of the Doctor of Philosophy program within the School of Nursing 
at Virginia Commonwealth University, the content below is to meet the dissertation 
requirements as established and approved by the School of Nursing. In lieu of the 
traditional dissertation, I have chosen to complete an alternative dissertation approved 
by my advisor and dissertation committee chair, Marianne Baernholdt. A grant 
application will replace Chapters I-III (i.e., statement of the problem, theoretical 
framework/review of literature, and methods). The grant follows the National Health 
Institutes (NIH) PHS 398 form. Chapters IV and V (i.e., findings and discussion and 
conclusion) follow the grant application. Finally, this introduction and a concluding 
narrative (Chapter VI) are intended to tie the grant and chapters IV and V into a 
comprehensive project. Results of this dissertation will be used to submit a manuscript 
to a peer reviewed nephrology journal. 
The proposed research study focuses on patients with chronic kidney disease 
(CKD). CKD is defined as “lasting damage to the kidneys that can get worse over time” 
(AKF, 2018). The progression of CKD is measured in five stages. The fifth and final 
stage of kidney disease, known as end stage renal disease (ESRD), occurs when the 
kidneys permanently fail to work (AKF, 2018). Patients with ESRD can choose 
conservative management for their kidney failure including palliative care, pursue a 
kidney transplant, or initiate dialysis. Dialysis is a treatment that takes over kidney 
functions (AKF, 2018). Dialysis can be administered via three modalities: hemodialysis 
in a dialysis facility, hemodialysis at home, or peritoneal dialysis offered in a facility or at 
home. This research proposal includes patients with ESRD receiving dialysis regardless 
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of modality. The purpose of this dissertation is to evaluate the association between 
dialysis facility performance in readmission measured by the Standard Readmission 
Ratio (SRR), dialysis facility characteristics and incident patient pre-dialysis nephrology 
care characteristics (i.e., patients that are within 90 days of first dialysis treatment for 
ESRD).  
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Grant Application 
Specific Aims 
Admissions and readmissions to the hospital represent major burdens for patients 
with ESRD. The frequency of 30-day readmissions for patients with ESRD receiving 
dialysis, regardless of modality, remained stable from 2007-2011 at approximately 39% 
(USRDS, 2018). However, the first reduction in readmission was noted in 2012-2013 
and has remained relatively stable at 37% (see Appendix 1, Figure 1 pg. 91). Prior 
research has evaluated characteristics of patients with ESRD receiving dialysis 
associated with readmission including social support and comorbidities (Flythe, Hilbert 
& Gilet, 2017; Flythe et al., 2016). Studies have also assessed hospital discharge 
characteristics (i.e., day of discharge and discharging service) and intervention studies 
have identified prevention strategies, such as frequent physician visits that impact 
readmissions in patients with ESRD receiving dialysis (Golestaneh, Bellin, Southern & 
Melamed, 2017; Erickson, Winkelmayer, Chertow & Bhattacharya, 2014). However, 
prior readmission research has not considered the impact of the setting in which the 
majority of patients with ESRD receive care for kidney failure, the dialysis facility. 
Characteristics of dialysis facilities have been associated with performance on various 
quality measures. For-profit dialysis facilities have been associated with increased 
hospitalization while not-for profit facilities have been associated with increased 
transplant waitlisting, and rate of transplantation (Dalrymple et al., 2014; Zhang, 
Thamer, Kshirsagar, Cotter & Schlesinger, 2014; Kucirka, Grams, Balhara, Jaar & 
Segev, 2011; Balhara, Kucirka, Jaar & Segev, 2012; Devereaux et al., 2002). Further, a 
prior study evaluating facilities offering hemodialysis to patients with ESRD found those 
 
 
 13 
associated with a dialysis chain to have increased mortality rates (Zhang, Cotter & 
Thamer, 2011). Additionally, prior research has found that when the number of dialysis 
stations (i.e., facility size) within a facility was less than or equal to fifteen, there was a 
significant increase in mortality among patients receiving hemodialysis (Yan et al., 
2013). Of the facilities included in the study, approximately 38.87% had 15 or less 
stations with 16-30 stations being the largest percentage of enrolled facilities (55.3%). 
Even with the adjustments for patient socioeconomic status (SES), facility 
characteristics, geographic region, and facility zip code SES (i.e., median household 
income, percentage of persons who completed high school, percentage of persons in 
poverty, and percentage of black population) the strong association between facility size 
below 15 stations and mortality remained statistically significant. Two additional studies, 
one completed in 2008 and another completed in 2018 also found small facility size was 
associated with an increased mortality risk in patients with ESRD receiving 
hemodialysis (Eisenstein et al., 2008; Yao, Chou & Huang, 2018). Finally, a facility’s 
length of operation has also been found to influence quality performance. Length of 
operation in relation to facility ownership has been shown to impact mortality. A study 
completed in 2010 found that hemodialysis facilities acquired by a large dialysis 
organization with less than two years of operating time have a significantly higher 
relative risk for death compared to facilities with longer tenure and consistent ownership 
(Van Wyck, Robertson, Nissenson, Provenzano & Kogod, 2010). The component that 
has not been previously evaluated is the relationship between dialysis facilities’ 
characteristics and the standardized readmission ratio (SRR), the quality measure used 
to evaluate dialysis facility performance in readmission. 
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The SRR is a measure of 30-day unplanned hospital readmission for dialysis 
patients discharged from any acute care hospital in the United States (CMS, 2017). 
While other standardized measures of quality for dialysis facilities (e.g., standardized 
mortality ratio, standardized hospitalization ratio) exclude patients within the first ninety 
days of care (called incident patients), this is not so for the SRR. This is of concern 
since the highest risk of mortality for incident patients occurred in the first two weeks of 
dialysis treatment with the risk of death 2.72-fold higher, and the risk of hospitalization 
1.95-fold higher when compared to patients who survived the first year of chronic 
dialysis (Chan et al., 2011). Additionally, over the first ninety days, the risk of mortality 
and hospitalizations remained elevated for incident patients (Chan et al., 2011; Broers, 
Cuijpers, van der Sande, Leunissen & Kooman, 2015). Given the inclusion of incident 
patients when the SRR is calculated, it is critical to examine the specific influence these 
patients may have on a facilities performance in readmission.  
Guided by the conceptual model, Shared Accountability in Readmission Outcomes 
within Dialysis (see Appendix, Figure 2, pg. 91), the proposed longitudinal descriptive 
study will evaluate the association between dialysis facilities’ SRR and dialysis facility 
characteristics and incident patient pre-dialysis nephrology care characteristics. This 
study will use four consecutive years (2013-2016) of data provided within the publicly 
available Dialysis Facility Report (DFR) dataset released in fiscal year 2018. The time 
period included in this dataset is of particular importance given that the Centers for 
Medicare and Medicaid Service (CMS) began using risk-adjusted measures of 
readmissions (i.e., SRR) for public reporting on the Dialysis Facility Compare (DFC) 
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website and for value-based purchasing as part of the ESRD Quality Incentive Program 
(QIP) in 2015 (USRDS, 2018). The Specific Aims of this project are: 
Specific Aim 1. Describe incident patient pre-dialysis nephrology care characteristics, 
dialysis facility characteristics and the standardized readmission ratio (SRR) among 
United States dialysis facilities over four years: 2013-2016.  
Specific Aim 2. Examine the associations between incident patient pre-dialysis 
nephrology care characteristics, dialysis facility characteristics and the standardized 
readmission ratio (SRR) among United States dialysis facilities over four years: 2013-
2016. 
Significance 
Reducing avoidable hospital readmissions is a key component of efficient, high-
quality healthcare. The CMS began evaluating hospital readmissions in 2013 after a 
provision in the Affordable Care Act established the Hospital Readmission Reduction 
Program (HRRP) (CMS, 2011). The HRRP requires Medicare to reduce payments to 
hospitals with readmission rates that exceed the national average (CMS, 2011). While 
penalty for readmissions was initiated among hospital providers, CMS broadened the 
scope of accountability by including dialysis facilities in 2015 (CMS, 2015). This was the 
first year the Final Rule included a readmission dialysis clinical performance measure 
(i.e., SRR) in the CMS ESRD QIP reimbursement penalty program.  
Efforts to reduce or prevent the occurrence of hospital readmissions through penalty 
programs such as the HRRP and ESRD QIP are necessary given the burden 
readmissions place on the >700,000 patients receiving dialysis. Patients with ESRD 
remain less than 1% of the total Medicare population; however, spending continues to 
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rise. Between 2015 and 2016, spending rose by 4.6% from $33.8 billion to $35.4 billion 
in paid Medicare claims among beneficiaries with ESRD (USRDS, 2018). This marks 
the fifth year of modest growth relative to historical trends (USRDS, 2018). A major cost 
inflator for patients with ESRD receiving dialysis is the use of hospital services for 
patient care. Overall, utilization of hospital services accounts for $11.7 billion (33%) of 
total Medicare expenditures (USRDS, 2018). The average readmission rate of patients 
with ESRD receiving dialysis is 37%, equating to $4.3 billion spent on readmissions 
alone. This cost includes potentially preventable hospital readmissions. A meta-analysis 
completed in 2011 showed that approximately 25% of unplanned readmissions among 
a wide variety of patients were preventable (van Walraven et al., 2011). Additionally, 
readmissions pose a significant emotional burden to patients and their caregivers. Prior 
research among patients with chronic conditions such as heart failure and chronic 
obstructive pulmonary disease has found that anxiety and poor quality of life are 
correlated with a higher risk of readmission (Volz et al., 2010; Raymond, Arrigain, 
Landers & Gorodeski, 2012; Osman, Godden, Friend, Legge & Douglas, 1997). A 
hospitalized patient with ESRD is also at risk for hospital-acquired infections and 
declines in weight, hemoglobin and albumin levels (Chan, Lazarus, Wingard & Hakim, 
2009). Given the economic burden and significant impact of hospital readmission on 
patients with ESRD receiving dialysis, a high priority area for research is to examine 
dialysis facilities as these entities deliver the majority of care to this patient population.  
Conceptual Framework 
The conceptual model for this study, Shared Accountability in Readmission 
Outcomes within Dialysis, (see Appendix 1, Figure 2, pg. 91) was developed using the 
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Quality Health Outcomes Model (QHOM) (Mitchell, Ferketich & Jennings, 1998) and the 
Open Systems Theoretical Framework (Katz & Kahn, 1978). Concepts from these 
models capture elements needed to evaluate and compare health care quality by 
relating multiple factors affecting quality of care to desired outcomes. The theoretical 
foundation of the model is derived from Katz and Kahn’s framework using Open 
Systems Theory. This theory adds to the model the idea that outcomes are produced 
through management of inputs. Patients with ESRD are the input to the system and are 
managed while receiving dialysis by interprofessional facility staff. Katz and Kahn refer 
to this as “transformation” indicating that inputs are transformed to effectively reach their 
output goal (Katz & Kahn, 1978). This is relatable to dialysis facility staff who follow 
clinical practice guidelines to manage the care of patients receiving dialysis. A dialysis 
facility’s goal is to assist patients in continuing to live a life compatible with their unique 
expectations. Further, dialysis facilities have performance goals established by federal 
regulations to ensure clinical processes (transformation) are appropriate. Dialysis 
facilities receive yearly feedback in the form of the ESRD QIP outcomes which reflect 
the effectiveness of the clinical processes. If a facility performs below the national 
average on the ESRD QIP, profit margins may be impacted due to associated 
reimbursement penalty. Thus, a facility is incentivized to identify opportunities for 
improvement (Borelli, Paul, & Skiba, 2016).  
In addition to the theoretical foundation provided by Open Systems Theory, the 
QHOM’s application of dynamic relationships between system, intervention, patient, and 
outcome, is utilized to demonstrate that these components not only act upon but 
reciprocally affect the other components. The four components of the model used for 
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this study are the dialysis facility (system), nursing/interprofessional team 
(interventions), incident patients on dialysis (patient), and hospital readmissions 
(outcome). Five reciprocal relationships exist in this model. The first relationship is 
between the dialysis facility and the nursing/interprofessional team. The 
nursing/interprofessional team implements dialysis clinical processes that influence the 
dialysis facility in which they work. But also, the dialysis facility influences how the team 
carries out their work by providing the necessary resources. Resource availability may 
be influenced by dialysis facility characteristics. The second relationship includes 
incident adult patients on dialysis (i.e. incident patients) and the 
nursing/interprofessional team. Incident adult patients on dialysis may possess specific 
characteristics (e.g., age, gender, race, ethnicity, comorbidity status, etc.) that impact 
not only the dialysis facility in which they dialyze, but also the way the dialysis team 
cares for them. Additionally, incident patients possess an additional characteristic 
conceptualized as pre-dialysis nephrology care (i.e., length of nephrology care, vascular 
access placement and primary dialysis modality: in-center hemodialysis, home 
hemodialysis, peritoneal dialysis, or kidney transplant) that impacts how the dialysis 
team provides care. The third relationship includes incident patients on dialysis and the 
dialysis facility. Patients’ clinical lab values and adherence to recommended treatment 
influence how a dialysis facility performs in quality measures. These quantifiable 
measures may ultimately impact a facilities financial viability, which in turn may 
influence the care the incident patient receives. The fourth relationship is between 
incident patients on dialysis and the outcome of hospital readmissions. Patients can 
decide to seek care at a hospital for any medical reason regardless of elapsed time 
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since prior hospitalization. Finally, the fifth relationship is between the dialysis facility 
and hospital readmissions. Readmissions attributed to a dialysis facility throughout the 
ESRD QIP SRR calculation may impact how a dialysis facility performs financially. In 
turn, how a dialysis facility coordinates care for their patient population impacts the 
occurrence of hospital readmissions.  
It is important to note that there are two ways to analyze the dialysis patient 
population: incident and prevalent patients. Incident patients refer to those with new 
cases of ESRD within a given year and are commonly tracked during the first ninety 
days of dialysis care to evaluate outcomes (USRDS, 2018). Prevalent patients refer to 
individuals with existing cases of ESRD within a given year (USRDS, 2018). Both 
groups of patients possess characteristics that may be significant in understanding the 
occurrence of hospital readmissions however, only incident patients will be included in 
this study due to their unique inclusion in the SRR measure and exclusion in all other 
standardized measures. This is the first study using the concepts in the Shared 
Accountability in Readmission Outcomes within Dialysis model. However, there is 
empirical evidence from the literature supporting the relationships between the four 
model components: dialysis facility, nursing/interprofessional team, incident adult 
patients on dialysis, and readmissions with other measures of quality within dialysis 
facilities including hospitalization, mortality, and transplantation. These relationships are 
described in the following paragraphs.  
Dialysis facility. The dialysis facility is the clinical unit providing treatment for 
kidney failure and is defined as “a group of people working together on an ongoing 
basis with business and clinical aims, linked clinical processes and a shared information 
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environment to produce performance outcomes” (Batalden, Godfrey, & Nelson, 2007, 
pg. 7). Dialysis facility characteristics considered for this study include staffing, profit 
status, size, chain membership, length of operation, geography (urban vs rural), and 
ESRD geographic network region (Northeast, South, Midwest, West). 
Adequate nursing staff is a frequent attribute analyzed in readmission prevention 
literature. The impact of staffing has been previously evaluated among readmissions in 
patients with heart failure. A study completed in 2016 found that readmission rates 
among patients with heart failure are significantly higher in hospitals with lower nurse 
staffing (Giuliano, Danesh & Funk, 2016). Dialysis facilities are known to have smaller 
patient care technician (PCT) to patient ratios compared to registered nurses to patient 
ratios (UM-KECC, 2018). PCTs typically care for fewer patients whereas nurses are 
responsible for a greater number of patients. PCTs are unlicensed personnel who carry 
out patient care under the supervision of registered nurses (RNs) or licensed practical 
nurses (LPNs). Prior research has shown staffing patterns vary based on dialysis facility 
characteristics including profit status, chain affiliation, and geographic region. In a study 
published in 2013, researchers found that ratios of RNs and LPNs to patients in for-
profit facilities were 35% lower, but the PCT to patient ratio was 16% higher compared 
to non-profit dialysis facilities (Yoder, Xin, Norris & Yan, 2013). Additionally, dialysis 
facilities associated with a dialysis chain had significantly lower RN and LPN to patient 
ratios than facilities not associated with a dialysis chain. Further, the study found 
regional differences in RN to patient ratios in dialysis facilities. Compared to the 
Northeast, ratios were 14% lower in the Midwest, 25% lower in the South and 18% 
lower in the Western regions of the United States. While prior research has not 
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investigated the association of readmissions and staffing among dialysis facilities, 
Zhang et al (2010) reported significantly higher mortality rates in for-profit dialysis 
facilities and lower numbers of RNs and LPNs per patient. The significant variation in 
staffing levels and empirical evidence on the influence of dialysis facility characteristics, 
warrants further investigation of the potential associations of staffing and readmissions. 
Profit status and the size of a dialysis facility are important dialysis facility 
characteristics to consider when examining structural characteristics influence on 
hospital readmissions. Prior research has shown that patients receiving hemodialysis in 
for-profit facilities had a 15% higher rate of hospitalization compared with those in non-
profit facilities (Dalrymple el al., 2013). Increased hospitalization creates index 
discharges initiating the vulnerability for rehospitalization post discharge. Further, a 
recent study published by Mathew et al., (2018) evaluated potentially avoidable 
readmissions in United States patients receiving hemodialysis. The researchers found 
that treatment at a for-profit-facility was associated with potentially avoidable 30-day 
readmissions. In addition to profit status, facility size has been evaluated in overall 
quality among dialysis facilities. A 2016 study by Zhang et al. utilized Dialysis Facility 
Compare (DFC) data to analyze overall dialysis facility quality and facility 
characteristics. This study found an inverse relationship between facility size and overall 
quality performance score. Specifically, the larger the facility the lower the total 
performance score on the ESRD QIP. The association between for-profit status and 
increased hospitalization and preventable readmissions as well as dialysis facility size 
with overall lower quality warrants further investigation related to readmissions.  
 
 
 22 
The geographic location of dialysis facilities (urban versus rural) has been 
previously investigated concerning pre-dialysis nephrology care. A study completed in 
2013 found that large urban and rural counties had lower percentages of patients 
receiving pre-dialysis nephrology care (25.7% and 26.9%) compared to small/medium 
size urban counties (31.6%) (Yan et al., 2013). Further, researchers found that the 
percentage of patients who received pre-ESRD nephrologist care for greater than 6 or 
12 months was lowest in large metropolitan (50.1% or 25.7% respectively) and rural 
(51.6% or 26.9%) and highest in medium/small metropolitan counties (56.6% or 31.6%). 
Additionally, a recent study evaluated potentially avoidable 30-day readmissions in the 
United States and found that readmission occurrence varied by state (Mathew et al., 
2018). However, no study was found that evaluated the occurrence of readmissions by 
geographic region as commonly used in the literature (i.e., Northeast, South, Midwest, 
West) (Saunders & Chin, 2013; Zhang, 2016). The significant association of rural and 
urban location with variation in incident patient pre-dialysis nephrology care as well as 
empirical evidence on variation in readmission by state, warrants further investigation of 
the relationship between location and the SRR.  
Incident adult patients on dialysis. Whether or not an incident patient receives 
nephrology care prior to initiating dialysis is an important characteristic to consider when 
evaluating a potential relationship among incident patients and dialysis facility 
performance on the SRR. Several studies suggest that pre-dialysis nephrology care is 
associated with cost-effectiveness and decreased mortality and morbidity (Black et al., 
2010; Kumar, Jeganathan & Amruthesh, 2012; Smart & Titus, 2011). Care prior to 
initiation of dialysis not only manages patients through the five stages of kidney failure, 
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but also provides ample time to prepare a patient for dialysis (Smart, Dieberg, Ladhani 
& Titus, 2014). Additionally, timely receipt of nephrology care is associated with slower 
CKD progression, lower rates of adverse outcomes, and improved quality of life 
(MCClellan et al., 2009; Smart, Dieberg, Ladhani & Titus, 2014; Diegoli, Silva, Machado 
& Cruz, 2015). Further, a systematic review published in 2011 revealed that patients 
receiving nephrology care prior to dialysis initiation had reduced mortality and 
hospitalizations, better uptake of peritoneal dialysis, and earlier placement of 
arteriovenous fistula with hemodialysis (Smart & Titus, 2011). Given the positive impact 
of pre-dialysis nephrology care on patients with ESRD, further research is warranted to 
understand the influence of pre-dialysis care on the incident population and 
subsequently on the SRR. 
Although pre-nephrology care is beneficial to patients with kidney failure, not all 
patients receive nephrology care prior to initiating dialysis. Additionally, the length of 
nephrology care received remains variable among incident patients receiving dialysis. In 
fact, 36% of patients newly diagnosed with ESRD received little or no pre-dialysis 
nephrology care with 21% of patients receiving no nephrology care prior to ESRD onset 
and 15% with unknown duration of pre-nephrology care (USRDS, 2018). Given the 
positive outcomes associated with nephrology care received prior to dialysis initiation, 
further research is needed to understand how the length of pre-dialysis nephrology care 
impacts dialysis facility performance on the SRR quality measure.  
One important component of pre-dialysis nephrology care is vascular access 
planning and placement. Patients can receive hemodialysis or peritoneal dialysis. 
Peritoneal dialysis requires placement of a catheter into the peritoneal cavity that can be 
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used shortly after placement. Hemodialysis requires the patient to have one of three 
vascular access types including: central venous catheter (CVC), arteriovenous fistula 
(AVF) and arteriovenous graft (AVG). Pre-dialysis nephrology care includes preparation 
and/or placement of a permanent access (i.e., AVF or AVG). Placement of an AVF is 
considered the gold standard vascular access for hemodialysis that requires time to 
mature before use (Santoro et al., 2014). While only 33% of incident patients initiate 
hemodialysis with an AVF in place, those with pre-nephrology care often have vein 
mapping completed and are scheduled for AVF placement shortly after initiation of 
dialysis (Santoro et al., 2014). The use of CVCs as a vascular access for hemodialysis 
has been associated with increased hospital readmissions (Flythe et al., 2016). Given 
the risk associated with CVC use among incident patients receiving hemodialysis, 
understanding the relationship of vascular access type and dialysis facility performance 
on the SRR is warranted.  
The level of an incident patients’ kidney function at the time of dialysis initiation is 
an important characteristic to consider when evaluating the relationship between 
incident patient characteristics and dialysis facility performance on the SRR. Prior 
research has focused on timing of dialysis initiation in relation to level of kidney function, 
measured by the estimated glomerular filtration rate (GFR) (Yu, Wong, Liu, Hebert & 
O’Hare, 2018). Observational data suggests that the level of kidney function at the time 
of dialysis initiation may be an important determinant of mortality (Clark et al., 2011). 
There are a number of factors associated with the decision to start dialysis in patients 
with CKD, however, a GFR <10mL/min is often associated with severe symptoms that 
require dialysis intervention (Chen, Lee & Harris, 2018). In addition to GFR, serum 
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creatinine can be measured as a sign of progression of kidney disease. Creatinine is a 
waste product that comes from normal wear and tear on muscles of the body (Counts, 
2015). Since serum creatinine levels rise as kidney disease progresses, a creatinine 
level greater than 1.2 milligrams for women and greater than 1.4 milligrams for men is a 
clinical indicator that the kidneys are failing. The relationship between incident 
population’s GFR, serum creatinine levels and a facility’s hospital readmissions is 
unknown. Given the inclusion of incident patients in the SRR measure, analysis of GFR 
and serum creatinine is necessary to provide insight on how the monitoring of these 
values through nephrology care prior to dialysis initiation impacts dialysis facility 
performance on the SRR.  
Additional laboratory values that can serve as measures of nephrology care for 
incident patients prior to dialysis initiation are hemoglobin and albumin. Hemoglobin 
reflects anemia management and can be reviewed in tandem with erythropoiesis-
stimulating agent (ESA) administration prior to initiating dialysis to understand pre-
dialysis nephrology care interventions. Anemia is associated with higher morbidity and 
mortality among patients with CKD (Babitt & Lin, 2012). Hemoglobin thresholds for 
patients with CKD are 12.0 grams per deciliter (g/dL) for females and 13.0 g/dL in men 
(Count, 2015). A recent study evaluated anemia treatment with ESAs before dialysis 
initiation and the impact on mortality in incident patients starting dialysis (Wetmore et 
al., 2018). Researchers found that a hemoglobin level greater than or equal to 9.0g/dL 
with ESAs before and after hemodialysis initiation was generally associated with lower 
post-initiation all-cause and cardiovascular mortality compared with a pre-dialysis 
hemoglobin less than 9.0g/dL in patients whose level subsequently improved with ESAs 
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after hemodialysis initiation (Wetmore et al., 2018). The impact of anemia management 
on mortality prior to initiating dialysis warrants further investigation of the influence of 
anemia on facility performance on the SRR quality measure. 
Albumin is an additional clinical measure captured among patients initiating 
dialysis. Albumin levels reflect dietary care interventions that are commonly 
implemented in patients suffering from CKD. Dietary care interventions include 
managing weight, avoiding foods high in sodium and eating the proper amounts and 
types of protein. As kidney disease progresses, patients may experience dietary issues 
as the disease impacts gastrointestinal nutrient absorption and muscle and fat wasting, 
thus dietary interventions may be needed (Vaziri, Yuan & Norris, 2013; Kalantar-Zadeh 
& Fouque, 2017). The protein-energy malnutrition and hypoalbuminemia at the initiation 
of dialysis is highly predictive of future hospitalization and mortality (Kliger, 2002 
Grange, Hanoy, Le Roy, Guerrot & Godin, 2013; Plantinga et al., 2007; Rocco, 
Frankenfield, Hopson & McClellan, 2006; Tentori et al., 2007). Given the association of 
mortality and hospitalization with albumin management, further investigation is 
warranted to understand this value in incident patients starting dialysis and 
readmissions. 
The primary dialysis modality utilized by incident patients with ESRD to receive 
treatment may influence the occurrence of readmissions. Based on 2016 USRDS data, 
87.3% of incident patients began treatment with hemodialysis (HD), 9.7% started with 
peritoneal dialysis (PD), and 2.8% received a preemptive kidney treatment (USRDS, 
2018). In a 2017 study, Perl et al. examined a cohort of 28,000 adults receiving dialysis 
in Canada. The authors followed patients after discharge for 30 days and found that the 
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risk for readmission among patients on PD therapy was higher compared with those on 
in-center HD therapy (adjusted HR, 1.19; 95% CI, 1.08-1.31). Another study completed 
in 2017 by Chan et al. utilized a national representative cohort of patients with ESRD 
and found that the readmission rate among patients on PD were considerably lower 
(14.6%) compared to patients on HD (37%) (Chan et al., 2017). While these findings are 
conflicting, the literature has presented considerable explanations addressing why 
patients on PD may experience increased readmissions. Patients receiving in-center 
HD have more frequent contact with health care providers and closer supervision to 
quickly address issues that arise (Shen, Dave & Erickson, 2017; Perl et al, 2017). In 
contrast patients on PD may wait longer after a hospital discharge to see a nurse or 
physician impeding the opportunity to address clinical issues to prevent a readmission 
in a timely manner (Shen, Dave & Erickson, 2017; Perl et al, 2017). While the evidence 
is inconclusive concerning whether or not a particular dialysis modality increases 
patients’ risks for hospital readmissions, the calculation of the SRR does not 
differentiate patient’s dialysis modality. Dialysis facilities are held accountable for 
readmissions regardless of the distribution of their patients by dialysis modality type 
(i.e., hemodialysis patients and peritoneal dialysis patients). The inclusion of primary 
dialysis modality at dialysis initiation provides insight to the unique challenges 
associated with modality type that may further influence a dialysis facilities performance 
on the SRR and warrants further investigation. In summary, when evaluating the SRR 
the literature supports the inclusion of pre-dialysis characteristics of incident patients 
that capture nephrology care received prior to initiating dialysis. The characteristics 
include recipient of pre-dialysis care, length of pre-dialysis care received, vascular 
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access type, level of kidney function (GFR), values including serum creatinine, 
hemoglobin and use of erythrocyte stimulating agent (ESA), albumin, and primary 
dialysis modality.  
Nursing/interprofessional team. The QHOM model identifies an intervention 
component. The interventions are conceptualized as dialysis care processes. These 
processes include interventions provided by the team to manage patients with ESRD 
such as vascular access, mineral metabolism, anemia management, and dialysis 
adequacy (i.e., how well dialysis removes waste from the blood), as well as ensuring the 
patient has access to appropriate treatment options based on their care preferences 
(i.e., home dialysis, in-center hemodialysis, transplant waitlisting) (Gomez, 2008). This 
study does not include concepts or variables for interventions due to the lack of such 
variables in the publicly available datasets.  
Hospital Readmissions. Hospital readmissions are defined as an unplanned 
admission to an acute care hospital within 30 days of discharge from the same or 
another acute care hospital (CMS, 2017). The accepted quality measure for 
readmissions among dialysis facilities is the SRR, which is the outcome measure of this 
study.  
There is a noticeable gap in the literature concerning how structural differences of 
dialysis facilities may influence performance on the SRR. In addition to dialysis facility 
characteristics, the pre-dialysis characteristics of a facility’s incident patients may 
influence the SRR. Whether the incident patients have received pre-dialysis care is 
associated with how they do when dialysis is started. Given the SRR is the only 
standardized measure that does not exclude the incident population in dialysis facility 
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performance calculations, research is needed to better understand how this specific 
population influences a dialysis facility’s performance on the SRR.  
Innovation 
The proposed study evaluates the association between dialysis facility performance 
in readmission measured by the SRR, dialysis facility characteristics, and incident 
patient pre-dialysis nephrology care characteristics. This study is innovative because it 
focuses on incident patient’s influence on the SRR over time. Dialysis facilities who 
receive incident patients without nephrology care prior to initiating dialysis (i.e., 
potentially sicker patients) has not been previously analyzed in relation to a dialysis 
facility’s performance on the SRR measure. The structure of dialysis facilities may not 
be equipped to appropriately manage incident patients in a way that prevents negative 
outcomes, such as hospital readmissions. Additionally, all other standardized quality 
measures used to evaluate dialysis facilities exclude incident patients within the first 90 
days of initiating treatment. This exclusion is due to the increased morbidity and 
mortality associated with this population as they transition to dialysis therapy (Chan et 
al., 2011; Broers, Cuijpers, van der Sande, Leunissen & Kooman, 2015). Findings 
examining structural characteristics can be used to draw attention to current policies 
related to facility’s evaluation in regard to readmissions. For example, the findings will 
inform whether certain staff compositions (i.e., nurse/PCT ratios) are warranted in 
outpatient dialysis facilities. In addition, the results of this study may draw attention to 
the need for new nursing roles to support incident patients’ transitions to dialysis. This 
transition may require care coordination and therefore new tasks and nursing roles not 
currently being practiced in dialysis settings. One example is the nurse navigator that 
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has grown in popularity among acute care facilities since the implementation of 
reimbursement penalty for readmission among the heart failure population (Di Palo, 
Patel, Assafin & Piña, 2017; Monza, Harris & Shaw, 2015). Nurse navigators are 
currently being trialed in dialysis facilities associated with ESRD Seamless Care 
Organizations (ESCO) which uses a comprehensive ESRD care model (The Lewin 
Group, Inc., 2017). There are only 37 ESCOs in the U.S., and they are partnerships with 
CMS and health care providers that evaluate the effectiveness of a new payment 
system and service delivery model (CMS, 2018). Finally, this is the first study to analyze 
dialysis facility performance on the SRR longitudinally. In 2015, CMS began publicly 
reporting risk-adjusted measures of readmissions and value-based purchasing. A 
longitudinal study will allow for evaluation of dialysis facility responses to these 
programs.  
Approach 
Research Design 
The proposed study is a descriptive, longitudinal, retrospective analysis using 
multivariate regression analysis on publicly available data to evaluate the association 
between dialysis facility performance in readmission measured by the SRR, and dialysis 
facility characteristics and incident patient pre-dialysis nephrology care characteristics. 
This study will use four years (2013-2016) of data from the Dialysis Facility Report 
(DFR) released in fiscal year 2018. The DFR allows for comparison of characteristics of 
a dialysis facility’s patients, patterns of treatment, transplantation, hospitalizations 
(admission, readmission, emergency department visits), and mortality to local and 
national averages. The primary aim of this study is to describe differences in dialysis 
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facility characteristics, incident patient pre-dialysis nephrology care characteristics, and 
facility performance in readmissions (SRR) across four years: 2013-2016. The 
secondary aim examines how dialysis facility characteristics and incident patient pre-
dialysis nephrology care characteristics affect facility performance in readmissions 
(SRR) across four years: 2013-2016.  
Study population. A total of 6,574 dialysis facilities are included in the DFR 2013-
2016 data. SRRs are not reported for facilities that have fewer than 11 index 
hospitalizations over the 4-year period due to the instability of the estimates. In this 
study, analysis will be restricted to dialysis facilities that reported an SRR for each year 
of the proposed study (i.e., 2013 through 2016). Additionally, facilities must have at 
least one incident patient within a study year to be included in the study. Overall, 1,146 
(17%) facilities were excluded for not meeting these criteria (1,068 for not having an 
SRR for all four years and 78 for not having any incident patients). Given the 
exploratory nature of this study and that the sample (5,428 dialysis facilities) is more 
than sufficient to investigate the aims, no power analysis is planned.  
Source of data. The primary data source for this study is the DFR-database. The 
University of Michigan Kidney Epidemiology and Cost Center (UM-KECC) produces the 
DFR with funding from CMS (CMS, 2017). The DFR database is compiled using the 
UM-KECC ESRD patient database derived from multiple data sources that are 
comprehensive for Medicare patients (e.g., CMS CROWNWeb [the ESRD National 
Patient Registry & Quality Measure Reporting System], payment records, Organ 
Procurement and Transplant Network, Social Security Death Master File, etc.). The 
DFR can be downloaded as one comma-separated values (CSV) file and does not 
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require access to multiple files or databases. Since the DFR only captures profit status 
and chain membership based on the last year of collected data and this is a longitudinal 
study, the Dialysis Facility Compare (DFC) database will be utilized to extract facility 
characteristics that may change over time due to facility acquisition (i.e., profit status 
and chain membership). The DFC is available as a CSV file and will be retrieved for all 
four years 2013-2016. This study will also use data obtained from the Area Resource 
File (ARF) to identify dialysis facilities as urban or rural based on county location. The 
ARF is publicly available data compiled from more than 50 databases to provide 
comprehensive county-level information on a variety of health care utilization, health 
professions and facilities, environmental, and socio-demographic topics (HRSA, 2018). 
The ARF dataset provides current as well as historic data for more than 6,000 variables 
for each of the nation’s counties, in addition to as state and national data (HRSA, 2018). 
The ARF database can be downloaded in Statistical Analysis System (SAS) format and 
has county, state, and national level files available. 
Study variables and measures. All variables are aggregated to the facility level. 
Variables for analysis are presented in table 1 (see Appendix 1, pg. 92) based on those 
suggested in the literature and data available in the DFR dataset. The primary outcome 
variable is the SRR. Potential factors associated with SRR include dialysis facility 
characteristics: staffing, profit status, chain membership, clinic size, length of operation, 
geographic location [urban vs rural], and geographic region [Northeast, South, Midwest, 
West] , and incident patient pre-dialysis characteristics: recipient of pre-dialysis 
nephrology care, length of pre-dialysis nephrology care, vascular access type, level of 
kidney function (GFR), creatinine, hemoglobin, use of ESA, albumin, and primary 
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dialysis modality. All variables used for this analysis are aggregated to the facility-level 
and described below in detail. 
SRR. The primary outcome variable is the SRR, calculated separately for each 
dialysis facility. The SRR reflects a dialysis facility’s performance in unplanned 
readmissions within 30 days following an index hospital discharge. Each year the SRR 
is calculated as the total number of observed readmissions that occurred over twelve 
months divided by the total number of expected readmissions within a facility resulting 
in a ratio. A value less than 1.0 indicates that a facility’s total number of readmissions 
are less than expected (i.e., high performing dialysis facilities), greater than 1.0 
indicates more readmissions than would be expected (i.e., low performing dialysis 
facilities), and equal to 1.0 indicates the facility performed as expected given national 
rates (i.e., average dialysis facilities) (CMS, 2017). The probability that a given 
discharge results in a readmission is based on a hierarchical logistic model that makes 
adjustments for the discharging hospital and for patient characteristics at the time of 
discharge including: age, sex, diabetes, BMI, duration of ESRD, comorbidities in the 
preceding year, the presence of a high-risk diagnosis, and length of hospital stay. The 
SRR is not calculated for dialysis facilities that have fewer than eleven index discharges 
in a year due to the small group of patients and resulting unstable statistics (CMS, 
2017). 
SRR exclusions. The SRR excludes unplanned readmissions to an acute care 
facility that occur 0-3 days post hospital discharge. These patients are excluded given 
the short readmission timeframe and inability for a dialysis facility to see a patient for 
assessment and intervention prior to the return to a hospital (CMS, 2017). Further 
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exclusions from the SRR include discharges from skilled nursing facilities, long-term 
care hospitals, rehabilitation hospitals, cancer hospitals, as well as separate dedicated 
units in hospitals for hospice, rehabilitation, and psychiatric care, patients discharged 
against medical advice, and hospitalizations occurring with a primary diagnosis of 
treatment of cancer, certain psychiatric conditions, or rehabilitation for prosthesis (CMS, 
2017).  
Readmission attribution for SRR. The attribution of hospital readmissions to dialysis 
facilities depends on which dialysis facility a patient was discharged to for dialysis 
treatment (CMS, 2017). This discharge is termed the index discharge and serves as the 
starting point for identifying readmissions. An index discharge is defined as the number 
of Medicare-covered hospital discharges occurring at acute-care hospitals in the 
calendar year for patients receiving dialysis treatment (CMS, 2017). In order to assign 
index discharges to dialysis facilities to initiate surveillance for readmissions, patient’s 
dialysis facilities are identified using a combination of Medicare dialysis claims, the 
Medical Evidence form (CMS-2728) and data from CROWNWeb (CMS, 2017). These 
data sources link the patient to a dialysis facility and treatment at the time of hospital 
discharge. Patients are included in a dialysis facility’s SRR from the first day of dialysis 
treatment. In other standardized measures (i.e., mortality and hospitalizations), patients 
are required to receive dialysis for more than 90 days before they are included in quality 
measure analysis. Additionally, if a patient transfers to a new facility the patient is 
included in the SRR immediately. In other standardized measures, patients must be in 
the dialysis facility to which they transfer for at least 60 days in order to be included in 
the quality measure analysis. Finally, patients are removed from the SRR analysis upon 
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withdrawal from dialysis treatment or are identified as lost to follow-up rather than 60 
days later, as done in other standardized measures (CMS, 2017). This difference is to 
prevent inflation of a facilities’ SRR by readmissions that occur when a patient is no 
longer receiving dialysis care from the facility. 
Dialysis facility characteristics. Staffing represents the total number of full- and 
part-time staff classified by job title: nurses and PCT. These values are then compared 
with the number of certified dialysis stations to create a ratio described as the number of 
nurses or PCTs per dialysis chair. Profit status identifies the for-profit or non-profit 
status of the dialysis facility. Clinic size refers to the total number of certified stations or 
“chairs” within a facility. Chain membership identifies dialysis facility association with a 
dialysis organization (e.g., DaVita, Fresenius, Dialysis Clinic Inc.) and is classified as 
yes or no in the DFC database. Length of operation identifies how long a dialysis facility 
has been open based on their CMS certification date. Geographic location reflects 
dialysis facilities classified as urban or rural based on county location obtained from the 
DFR dataset and matched to the ARF county-level file. Geographic region refers to the 
classified geographical region by ESRD Network in which a dialysis facility is located. 
There are eighteen ESRD Networks in the U.S. which are divided into four regions: 
Northeast, Midwest, South, and West (Saunders & Chin, 2013).  
Adult incident patients on dialysis. Incident patient characteristics included in the 
DFR are based on the total number of patients with submitted CMS-2728 forms. This is 
a medical evidence form required by CMS for each new patient receiving dialysis (CMS, 
2017). Recipient of pre-dialysis nephrology care identifies the percentage of patients 
who have and who have not received nephrology care prior to initiating dialysis. Length 
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of pre-dialysis nephrology care captures the percentage of patients under the care of a 
nephrologist prior to the start of ESRD therapy and is stratified by length of time (never, 
<6 months, 6-12 months, >12 months, and missing/unknown). Vascular access type at 
start of dialysis identifies the percentage of patients on hemodialysis with central venous 
catheters, grafts, or fistulas at their first outpatient renal replacement treatment. Average 
lab values reflect those measurements obtained prior to initiating dialysis including level 
of kidney function measured by GFR (mL/min; ranging from 0-30), serum creatinine 
(mg/dL; ranging from 0-33), hemoglobin (g/dL; ranging from 3-18), and serum albumin 
(g/dL; ranging from 0.8-6.0). These values are collected at the time of ESRD diagnosis 
as reported on the CMS-2728 and averaged among all incident patients to create a 
facility average. Use of ESA describes the percent of patients who received ESA prior to 
initiating dialysis. Primary dialysis modality describes a facility’s percentage of patients 
receiving dialysis treatment by modality type including hemodialysis, continuous 
ambulatory peritoneal dialysis (CAPD)/continuous cycling peritoneal dialysis (CCPD). 
Data Collection. Since the proposed study is using publicly available, de-identified 
data, aggregated to the dialysis facility-level that does not involve human subjects the 
study is exempt from IRB approval. Data will be extracted from the UM-KECC DFR 
dataset for fiscal year 2018, Archive DFC datasets (10/20/2016, 10/08/2015, 
10/23/2014, 9/12/2013) and ARF separately. The DFC database will be used to extract 
yearly ownership and profit status facility characteristics based on CMS certification 
number (CCN) and the ARF dataset will be used to extract information on rural and 
urban geographic location of dialysis facilities based on county location. Additionally, 
urban and rural classifications will be coded into nine categories correlating to 
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population size using the Rural-Urban Continuum Codes developed by the U.S. 
Department of Agriculture in 2013 (see Appendix 1, Table 2, pg. 90). These codes will 
be transformed into four categories obtained from ARF as done in prior studies (Yan et 
al., 2013). The DFR and DFC will be combined for corresponding years based on the 
CCN. Then the new file will be combined with ARF data for the corresponding years 
based on dialysis facility county location. Data elements to be extracted from the 
database are listed in table 1 (see appendix 1, pg. 92). Data will be analyzed using SAS 
9.4 (SAS Institute, Cary, NC, USA). 
Data Analysis. The statistical analysis for this study is described below. 
Aim 1. Describe differences in incident patient pre-dialysis nephrology care 
characteristics, dialysis facility characteristics and the standardized readmission 
ratio (SRR) among United States dialysis facilities over four years: 2013-2016.  
To address this aim, descriptive statistics will be calculated to describe the 
facilities’ incident patient pre-dialysis nephrology care characteristics: recipient of pre-
dialysis nephrology care, length of pre-dialysis nephrology care, vascular access type, 
level of kidney function (GFR), serum creatinine, hemoglobin, use of ESA, albumin, and 
primary dialysis modality, dialysis facility characteristics: staffing, profit status, chain 
membership, size, length of operation, geography (urban v. rural), ESRD geographic 
Network (Northeast, South, Midwest, West), and facility performance on the SRR. 
Descriptive statistics will include means, medians, standard deviations, and ranges for 
the continuous variables, as well as counts with frequencies for the categorical 
variables. Descriptive statistics will be calculated for all four-performance years (2013-
2016). Chi-square tests for categorical variables and analysis of variance (ANOVA) for 
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continuous variables will be used to determine differences in variables across the four 
years (2013-2016).  
Aim 2. Examine the associations of incident patient pre-dialysis nephrology care 
characteristics and dialysis facility characteristics with the standardized 
readmission ratio (SRR) among United States dialysis facilities over four years: 2013-
2016. 
To address this aim, a series of analyses will be performed. The data used in this 
study are longitudinal meaning that variables of interest are measured four times. 
Statistical analysis of longitudinal data requires accounting for possible between-
subjects heterogeneity and within-subject correlation (Delwiche & Slaughter, 2012). The 
assumption of independence is violated in this study, as each dialysis facility provides 
more than one data point for each variable (Bakdash & Marusich, 2017). In order to 
account for the correlation within the same dialysis facility, mixed linear model (MLM) 
regression will be used to test associations between independent variables and SRR in 
a univariate fashion while accounting for within-subject (facility) variability. In 
subsequent regression analyses, variables achieving statistical significance in the 
univariate analysis will be considered candidate variables for the final model. Next, 
multivariable regression using an MLM will be used to evaluate incident patient pre-
dialysis nephrology care characteristic and dialysis facility characteristics associated 
with SRR. 
Potential issues with variables that are closely related (i.e., multicollinearity) will 
be assessed during the analysis and signs of the parameter estimates will be observed 
to see if they are in the expected direction. If variables are identified as being 
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multicollinear, models will be fit with only one of the variables at a time and then 
simultaneously to see if there are any substantive differences in results. The Wald 
statistic will be used to test whether the variable is making a significant contribution to 
the prediction of the outcome, specifically, whether the explanatory variable’s coefficient 
is significantly different from zero (Hosmer & Lemeshow, n.d.). The Wald statistic will be 
interpreted with attention paid to the standard error and deviance (goodness of fit) to 
mitigate false conclusions about the contribution of an explanatory variable. If there is 
doubt about the relevance of an explanatory variable, a prior model without the variable 
will be compared to a model with the variable to see whether the reduction in deviance 
is statistically significant (Hosmer & Lemeshow, n.d.). The effect size of the explanatory 
variables will be evaluated based on odds ratios to determine the size or magnitude of 
the association of explanatory variables with the SRR. Additionally, outliers may 
severely affect statistical output. To compensate for this potential threat, regression 
analyses will be performed with attention paid to the entry method of explanatory 
variables. Entry method will be completed in two manners: forward selection and 
backward elimination. Stepwise methods will not be completed because empirical 
evidence is available to support the importance of selected explanatory variables for this 
study.  
Missing Data. With any observational database, missing data are inevitable. 
Patterns and quantity of missing data within the sample will be documented. Various 
strategies will be considered for missing data. Listwise deletion will be considered to 
handle dialysis facilities with large amounts of missing data for the explanatory variables 
(Kang, 2013). Prior research using the DFR dataset found that <2.9% of data were 
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missing for covariates therefore, listwise deletion is a reasonable strategy (Patzer, 
Plantinga, Krisher & Pastan, 2014; Kang, 2013). If missing data is larger than previous 
estimates, regression imputation is another strategy that will be considered to handle 
missing data. Imputation is the process of replacing missing data with estimated values. 
This technique preserves available data by replacing missing data with a probable value 
estimated by other available information (Kang, 2013). Given the longitudinal nature of 
this study a third method, last observation carried forward, may be an additional 
strategy to handle missing data. (Hamer & Simpson, 2009).  
Limitations. The proposed study will perform secondary analysis using existing 
observational datasets; therefore, the results will reveal associations and not causality. 
The accuracy of the data and its ability to be appropriately interpreted through this study 
is dependent upon the original data source from which the DFR is produced. Data 
sources retrieved by the University of Michigan responsible for developing the DFR 
dataset, is dependent upon dialysis facility data entry. Accuracy of facility reported data 
is a limitation due to the retrospective nature of this study and inability to validate data. 
Selection bias is an inherent limitation of this study due to the data’s retrospective 
nature and dependence on this specific database to investigate the study as proposed. 
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Chapter IV: Findings 
Data Management 
 Data management for this study consisted of six distinct tasks that supported the 
construction of eight independent variables from disparate data sources. These six 
tasks included: one task using the dialysis facility compare (DFC): 1) recoding of profit 
status and chain association variables for 2014, two tasks using the Area Resource File 
(ARF): 2) construction of the geographic location and 3) construction of geographic 
region variables, and three tasks using the Dialysis Facility Report (DFR): 4) 
calculations to support the development of the years in operation, 5) calculations for the 
creation of patient care tech (PCT) and registered nurse (RN) ratios and 6) creation of 
dialysis modality variables.  
The first data management task involved recoding profit status and chain 
association variables. The need to recode the profit status and chain association 
variables was identified after suspicious fluctuation was noted in data extracted from the 
DFC database. A large number of dialysis facilities switched ownership status between 
2013 and 2014 but returned to their prior status in 2015 and maintained that status in 
2016. This fluctuation was potentially caused by insignificant name changes from 2013 
to 2014 that triggered a logic attribution change (e.g., American Renal Associates ARA 
to American Renal Associates; Regional-Beaumont Hospital to Beaumont Hospital; 
Dialysis Clinic, Inc. DCI to Dialysis Clinic, Inc., etc.). Additionally, the variable type for 
profit status (OWNTYPE) was changed from numeric (i.e., 1=Profit and 2=Non-Profit) in 
2013 to character (i.e., Profit and Non-Profit) in years 2014-2016. The code for chain 
association (CHAINYN) was changed from single characters (i.e., Yes=Y and N=No) in 
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2013 to full-text (i.e., Yes and No) in years 2014-2016. Thus, dialysis chain names and 
corresponding profit status was identified using all four years of DFC databases (2013-
2016) to validate facility chain association and profit status across years. A control table 
was created for chain name using the validated chain association and profit status. 
Binary variables were created for chain association (1 indicating yes and 0 indicating 
no) and profit status (1 indicating for-profit and 0 indicating not-for-profit) for each of the 
four years (2013-2016). 
 The second data management task involved converging data to create a 
geographic variable for rural/urban location. The DFR only contains an identification for 
city variable. To identify whether a facility was located in a rural/urban county, it was 
necessary to cross reference from the DFR database to the DFC which includes a 
county variable. After dialysis facility county location was identified, county names were 
matched to their corresponding federal information processing standards (FIPS) codes. 
The FIPS codes allow for matching to rural-urban continuum codes (RUCC). RUCC 
codes add geographic descriptions to locations (see Appendix 1, table 2, pg. 94). RUCC 
codes were compared with codes from the Area Resource file (ARF) to determine urban 
and rural classification of dialysis facilities as done in prior studies in the literature (see 
Appendix 1, table 2, pg. 94; Yan et al., 2013). A variable was constructed to indicate 
dialysis facility geographic location ranging from values 1-4; 1 large metropolitan 
counties, 2 medium/small metropolitan counties, 3 suburban counties, and 4 rural 
counties (Yan et al., 2013). However, data for additional U.S. territories and Islands 
included in the DFR data were not available in the ARF (e.g., Guam, Virgin Islands, and 
America Samoa). Therefore, nine dialysis facilities were excluded from the study. 
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 The third data management task supported the creation of the geographic region 
variable. The end stage renal disease (ESRD) Network variable was extracted from the 
DFR which classifies networks into geographic regions (Saunders & Chin, 2013). 
Networks 1, 2, 3, 4 were classified as Northeast; Networks 5, 6, 7, 8, 13, 14 were 
classified as South; Networks 9, 10, 11, 12 were classified as Midwest; and Networks 
15, 16, 17, 18 were classified as West (see Appendix 2, Table 3 & Figure 3, pg. 95). 
This classification is largely congruent with the U.S. Census Bureau’s map of U.S. 
regions. However, the ESRD geographic region for this study was determined by how 
the majority of states classified based on ESRD Network association. For example, 
Kentucky which is associated with Network 9, containing primarily Midwest states, was 
classified as Midwest instead of South, as it is in the U.S. Census Bureau’s 
classification. Additionally, Delaware is associated with Network 4 which contains 
Delaware and Pennsylvania. Since Pennsylvania is classified as a northeast state, 
Delaware was classified as northeast as well.  
 The three remaining data management tasks involved the creation of four 
independent variables from the DFR database: years in operation, patient care 
technician (PCT) and registered nurse (RN) ratios, and dialysis modality (i.e., in-center 
hemodialysis dialysis [ICHD] only, home only, ICHD and home). Years in operation was 
created using the initial Medicare certification date (MM/DD/YYYY) to calculate how 
many years a facility had been in operation in each study year (2013-2016; e.g., 2013 
minus certification date). The PCT and RN ratios were calculated using staffing data. 
First, the numbers of full-time and part-time PCTs and RNs were extracted for each 
study year. Then, to create a ratio, the total number of certified dialysis chairs (i.e., clinic 
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size) was divided by the total number of PCTs and RNs. The last variable that was 
created was facility services by modality type. The modality variables (i.e., 
hemodialysis, home hemodialysis, and home peritoneal dialysis) reported for all patients 
were used to create a facility modality service numeric variable ranging from 1 to 3. 
Facilities with 100% of their patient population receiving in-center hemodialysis were 
classified as “in-center hemodialysis (ICHD) only” coded as 1. Facilities reporting patient 
populations on ICHD and home (HHD, CAPD, or CCPD) were classified as “ICHD and 
Home” coded as 2. Facilities with 100% of their patient population receiving home 
hemodialysis (HHD) or peritoneal dialysis (CAPD or CCPD) were classified as “home 
only” coded as 3. Creating modality service variables for dialysis facilities included in 
this study was done using actual patient data, as described above, due to the fact that 
dialysis facilities can be certified for a modality but not currently offering that service at 
their facility. Using patient data allows for an accurate interpretation of services offered 
by dialysis facilities in real-time. Following the completion of the data management tasks 
there were 27 independent variables including 10 dialysis facility characteristics and 17 
incident patient characteristics, and one outcome variable (SRR) for analysis.  
Sample 
A total of 6,574 dialysis facilities were available in the DFR 2013-2016 data. 
Dialysis facilities were only included if they reported standardized readmission ratio 
(SRR) for all 4 years (2013 to 2016). SRRs are not included in the DFR data set if a 
facility reports fewer than 11 index discharges within a year. Thus 1,068 facilities were 
excluded. An additional 78 facilities were excluded because they did not have at least 
one incident patient reported per study year. Finally, an additional nine facilities located 
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in U.S. territories or islands (e.g., Guam, Virgin Islands, and America Samoa) were 
excluded due to the inability to extract geographic location data from the ARF for 
appropriate urban and rural assignment. Therefore, the study included 5,419 dialysis 
facilities located in all 50 states, the District of Columbia, and Puerto Rico. Table 4 
reflects the total number of facilities across all four study years that were included for 
the descriptive analyses for the primary aim and the regression analyses for the 
secondary aim. Total observations reflects the total number of facilities across the four 
study years (2013-2016) included in each aim. The variation in the sample for the 
secondary aim (table 4) resulted from missing data. For the secondary aim facilities with 
missing data for any of the variables were excluded in that year.  
Table 4 
Number of Dialysis Facilities included in each aim for year studied 
 
2013 2014 2015 2016 
Total 
Observations 
2013-2016 
Primary Aim 5,419 5,419 5,419 5,419 21,676 
Secondary Aim 5,345 5,330 5,350 5,348 21,373 
 
Analysis for Missing Data 
A common problem associated with longitudinal studies is the prevalence of 
missing data. Overall, 4,089 (75%) of facilities had zero missing data for all independent 
variables included in the study. Over the course of the four study years, 25% of the 
sample dialysis facilities were missing data for at least one independent variable. Table 
5 (see appendix 2, pg. 95) displays a breakdown of missing data by year. Missing data 
were reviewed for independent variables prior to the regression analyses. Of the study’s 
27 independent variables, only four had missing data in one or more years. Table 6 
reviews missing data by independent variables.  
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Table 6 
Missing Data by Independent Variable of Total Sample Dialysis Facilities (n=5,419) 
Variable (n, %) 2013 2014 2015 2016 
RN Ratio 74 (1.37%) 89 (1.64%) 69 (1.27%) 71 (1.31%) 
PCT Ratio 258 (4.76%) 268 (4.95%) 246 (4.54%) 251 (4.63%) 
Avg. Albumin 389 (7.18%) 457 (8.43%) 498 (9.19%) 532 (9.82%) 
Avg. Hemoglobin g/dL 240 (4.43%) 302 (5.57%) 312 (5.57%) 351 (6.48%) 
Avg. GFR mL/min 0 (0.00%) 1 (0.02%) 0 (0.00%) 0 (0.00%) 
Note: RN= registered nurse, PCT=patient care technician, Avg.=average, 
GFR=glomerular filtration rate 
 
Due to the random structure of missing data the sample size was not altered, and all 
variables were included for the descriptive statistics analysis. To examine potential 
impact of missing data for the secondary aim, a mixed linear model using the PROC 
MIXED procedure in SAS® was used to assess the correlational structures and 
variability changes between repeated measurements on dialysis facilities across time. 
PROC MIXED has the capacity to handle unbalanced data when the data are missing at 
random (Littell, Milliken, Stroup, Wolfinger & Schabenberger, 2006). PROC MIXED 
does not impute missing data, but instead ignores data for variables where it is missing 
(Littell, Milliken, Stroup, Wolfinger & Schabenberger, 2006). Average albumin had the 
highest rates of missing data across the four study years (2013-2016). The rate of 
missing hemoglobin values increased from 2013 to 2016 (4.43% to 6.48%) and average 
GFR had the lowest rate of missing data with only one facility missing average GFR 
data in 2014.  
Results for Primary Aim 
 The primary aim was to describe differences in dialysis facility characteristics, 
incident patient pre-dialysis nephrology care characteristics, and the SRR among United 
States dialysis facilities over four years: 2013-2016. Descriptive statistics for the study’s 
27 variables across the 4 years are depicted in Table 7. Continuous variables have 
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mean and standard deviation calculations displayed by year. Categorical variables have 
counts (n) and frequencies (%) displayed by year. 
Table 7 
Descriptive Statistics for dialysis facilities receiving an SRR 2013-2016 
Dialysis Facility 
Characteristics 2013 2014 2015 2016 
Incident Pts  19.48 (13.26) 19.53 (12.87) 19.53 (12.90) 18.80 (12.51) 
Years in Operation  14.56 (9.94) 15.56 (9.94) 16.56 (9.94) 17.56 (9.94) 
Clinic Size  18.52 (8.08) 18.63 (8.14) 18.74 (8.17) 18.82 (8.16) 
RN Ratio  4.00 (2.53) 3.88 (2.33) 3.86 (2.33) 3.85 (2.36) 
PCT Ratio  3.57 (2.59) 3.48 (2.61) 3.33 (2.37) 3.25 (2.25) 
Chain Association  
Yes 4,659 (86%) 4,709 (87%) 4,753 (88%) 4,787 (88%) 
No 760 (14%) 710 (13%) 666 (12%) 632 (12%) 
Profit Status  
For-Profit 5,010 (92%) 5,008 (92%) 5,004 (92%) 4,996 (92%) 
Not-for-Profit 407 (8%) 411 (8%) 415 (8%) 423 (8%) 
Facility Services  
In-Center Hemodialysis   
    Only (ICHD) 
2,078 (38%) 1,979 (37%) 1,860(34%) 1,916(35%) 
ICHD & Home Dialysis 3,294 (61%) 3,406 (63%) 3,537 (65%) 3,479 (64%) 
Home Only 47 (0.9%) 34 (0.6%) 22 (0.4%) 24 (0.4%) 
Geographic Region  
Northeast 796 (15%) 796 (15%) 796 (15%) 796 (15%) 
South 2,340 (43%) 2,340 (43%) 2,340 (43%) 2,340 (43%) 
Midwest 1,315 (24%) 1,315 (24%) 1,315 (24%) 1,315 (24%) 
West 968 (18%) 968 (18%) 968 (18%) 968 (18%) 
Geographic Location  
Large Metropolitan 2,824 (52%) 2,824 (52%) 2,824 (52%) 2,824 (52%) 
Medium/Small Metro 1,617 (30%) 1,617 (30%) 1,617 (30%) 1,617 (30%) 
Suburban 679 (13%) 679 (13%) 679 (13%) 679 (13%) 
Rural 299 (6%) 299 (6%) 299 (6%) 299 (6%) 
      Incident Patient Characteristics 
Received Pre-Dialysis Care  
% No 25.69 (20.40) 24.87 (20.85) 22.82 (20.36) 21.14 (19.71) 
% Yes 61.40 (25.15) 61.42 (25.60) 62.54 (25.79) 63.92 (25.98) 
% Unknown 12.90 (21.59) 13.70 (22.36) 14.64 (23.34) 14.93 (23.31) 
Length of Pre-Dialysis Care  
% < 6 Months 13.69 (15.82) 13.88 (16.35) 13.81 (16.49) 13.86 (16.31) 
% 6-12 Months 19.04 (16.59) 18.83 (16.72) 19.33 (17.09) 19.31 (17.08) 
% > 12 Months 28.67 (22.30) 28.71 (22.67) 29.40 (23.12) 30.75 (24.07) 
Vascular Access 1st Tx  
% AVF 17.29 (14.44) 17.10 (14.55) 17.15 (14.75) 17.12 (15.16) 
% AVG 2.85 (5.66) 3.07 (5.95) 3.08 (6.03) 3.04 (6.11) 
% CVC 77.75 (18.88) 77.89 (18.78) 77.90 (18.83) 77.91 (19.31) 
% AVF Present 35.67 (20.73) 34.29 (20.77) 33.88 (20.55) 33.64 (20.73) 
Primary Dialysis Modality  
% HD 91.63 (18.24) 91.75 (17.97) 91.76 (17.92) 91.85 (17.75) 
% PD 8.37 (18.24) 8.25 (17.97) 8.24 (17.92) 8.15 (17.75) 
Facility Average Lab Values  
Albumin  3.15 (0.34) 3.14 (0.34) 3.16 (0.34) 3.16 (0.34) 
Serum Creatinine  6.38 (1.32) 6.45 (1.32) 6.46 (1.31) 6.43 (1.32) 
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Hemoglobin  9.48 (0.63) 9.40 (0.64) 9.35 (0.66) 9.30 (0.66) 
GFR  10.89 (1.92) 10.77 (1.92) 10.75 (1.97) 10.74 (1.90) 
% Received ESA 14.80 (16.36) 14.10 (16.29) 12.92 (15.68) 12.77 (15.93) 
Note: Pts=patients, RN=registered nurse, PCT=patient care tech, Tx=treatment, 
AVF=arteriovenous fistula, AVG=arteriovenous graft, CVC=central venous catheter, 
HD=hemodialysis, PD=peritoneal dialysis, ESA=erythropoietin stimulating agent 
 
Dialysis Facility Characteristics. The average number of incident patients 
across the four study years remained relatively consistent (range: 18.80 to 19.53 
patients). The average number of facility years in operation ranged across the four 
years from 14.56 to 17.56. The stepwise increase in the mean across the four study 
years reflects facilities included in the sample increase in years of operation by one 
each year. Clinic size remained stable across the four years with an average of 19 
certified dialysis chairs. However, even though the average appeared stable across the 
four years, the number of certified dialysis chairs varied from year-to-year among 11% 
(n=575) of the facilities. Of the 575 facilities with variation, 75% increased the number of 
chairs (n=422) and 25% decreased their number of chairs (n=153). The differences in 
averages of the PCT and RN ratios decreased across the study years with 4.0 to 3.85 
chairs per RN and 3.57 to 3.25 chairs per PCT. Chain association and profit status 
varied slightly across the four years. The majority of facilities included in the sample 
were associated with a dialysis chain (range= 86-88%) and were for-profit (92%). 
Facility services varied across the four years among the study sample with single 
service clinics showing a decline from 2013-2015 (ICHD went from 38% to 35% and 
Home only went from 0.9% to 0.4%) and multi-service clinics increasing (61% to 64%). 
The majority of dialysis facilities included in the sample were located in the south (43%) 
with the smallest portion of facilities located in the northeast (15%). Additionally, the 
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majority of facilities were located in a large metropolitan county (52%) with the smallest 
portion of facilities located in rural counties (6%).  
Incident Patient Characteristics. The majority of incident patients received pre-
dialysis nephrology care and the rate increased across the four study years (61.40% to 
63.92%). However, the variation among facilities was high demonstrated by standard 
deviations greater than 25%. The length of pre-dialysis nephrology care varied across 
the study years with means increasing as the length of care increased. For example, 
less than 6 months of pre-dialysis nephrology care ranged from 13.69% to 13.86%, 6-12 
months ranged from 19.04% to 19.31%, and greater than 12 months ranged from 
28.67% to 30.75%. The rates of vascular access used at first outpatient dialysis 
remained relatively stable across the four study years with the largest majority of 
patients dialyzing via a catheter (78%) and the smallest portion dialyzing via AV graft 
(3%). The rate of patients starting dialysis with a fistula in place decreased from 35.67% 
to 33.64% across the four years. The primary dialysis modality remained stable across 
the four study years with approximately 92% of patients receiving hemodialysis and 8% 
receiving peritoneal dialysis. Additionally, the facilities average patient lab values 
remained similar across the four study years with average serum albumin 3.2g/dL, 
serum creatinine 6.5mg/dL, and glomerular filtration rate (GFR) 10.7mL/min however, 
hemoglobin declined from 9.48 to 9.30. There is a noted decrease in administration of 
erythropoietin stimulating agent (ESA) across the four study years (14.80% to 12.77%). 
However, the standard deviation is large (~16) indicating variation in incident patients 
receiving ESA prior to dialysis initiation. 
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SRR. Among the 5,419 dialysis facilities, the mean observed index admissions 
decreased across the four study years but rebounded in 2016 (range: 90.16 to 92.00; 
table 8). Index admissions initiate the 30-day window of time a discharged patient is 
tracked for a readmission (CMS, 2018). Large variation exists among facilities in index 
admissions as noted by standard deviations greater than 55. The average readmission 
that occurred among the dialysis facilities was stable at approximately 24 from 2013 to 
2015 and declining slightly in 2016 to 23. Expected readmission followed a similar 
pattern (range: 23-22). The average readmission that occurred was greater than those 
expected among dialysis facilities in all four study years. The mean SRR remained 
stable across all four study years at 0.99. 
Table 8 
Descriptive Statistics for SRR Performance 2013-2016 
Metric 2013 2014 2015 2016 
Index Admissions 92.00 (59.02) 90.59 (56.68) 90.16 (55.50) 91.29 (55.39) 
Actual Readmissions 24.88 (18.79) 24.30 (18.21) 24.20 (17.83) 23.02 (16.69) 
Expected Readmissions 23.95 (15.86) 23.47 (15.06) 23.45 (14.83) 22.37 (13.89) 
SRR 1.00 (0.27) 0.99 (0.27) 0.99 (0.27) 0.99 (0.27) 
 
Figure 4 displays the SRRs, or the ratio of observed to expected readmissions for 
dialysis facilities included in this study. The middle line represents an SRR of 1.0 where 
the observed number of readmission equals the expected number of readmissions. 
Facilities to the right of the line are performing worse than expected (SRR > 1.0) and 
facilities to the left of the line are performing better than expected (SRR < 1.0). Thirty-
four dialysis facilities (6%) had zero readmissions within the four study years. These 
facilities had index admissions, but their patients were not readmitted to the hospital 
within the 30-day readmission window. 
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Figure 4. Standardized Readmission Readmissions (SRRs) among study dialysis 
facilities, 2013-2016 
 
SRR correlation analysis. Spearman correlation coefficients were used to 
examine the associations between the dialysis facility characteristics, incident patient 
characteristics and SRR. Dialysis facility and incident patient characteristics that were 
significantly correlated with SRR are presented in table 9 (see appendix 3, pg. 96). 
Spearman’s correlation is a statistical measure of the strength of a monotonic 
relationship between paired data. The closer r is to 1 the stronger the monotonic 
relationship (Royden & Fitzpatrick, 2010). The strength of a correlation can be classified 
by the r value: .00-.19=very weak, .20-.39=weak, .40-.59=moderate, .60-.79=strong, 
and .80-1.0=very strong. The percent of patients receiving pre-dialysis nephrology care, 
percent using an AVF at first dialysis treatment, percent AVF present (i.e., maturing 
AVF at dialysis initiation), and percent of patients who received greater than twelve 
months of pre-dialysis nephrology care had a very weak negative correlation with SRR. 
Clinic size, percent of patients with an unknown length of pre-dialysis nephrology care, 
percent using a CVC at first dialysis treatment, and the number of incident patients 
within a dialysis facility had a very weak positive correlation with SRR. All other 
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variables showed no correlation with SRR. All Spearman correlation results of study 
variables can be viewed in table 10 (see appendix 3, pg. 97). 
Results for Secondary Aim 
 The secondary aim was to examine the associations between incident patient 
pre-dialysis nephrology care characteristics, dialysis facility characteristics and the 
standardized readmission ratio (SRR) among United States dialysis facilities over four 
years: 2013-2016. Analysis for the secondary aim consisted of two tasks. First 
multicollinearity among independent variables was reviewed. Then a repeated-
measures multivariable regression model was run to analyze associations among 
independent variables and SRR. 
Analysis for Multicollinearity 
 Multicollinearity was a concern due to the numerous independent variables and 
their potential correlation with each other. Two statistical procedures were performed to 
better understand collinear relationships among the independent variables including a 
1) pairwise Pearson correlation and 2) regression analysis using PROC Reg in SAS. 
First, to assess the correlation between variables, a pairwise Pearson correlation test 
was used to identify the strength of linear relationships between continuous numeric 
variables. A matrix of correlation coefficients is presented in table 11 (see Appendix 3, 
pg. 98). Correlations are considered to have collinear relationships if r is equal to or 
greater than 0.50 (Mukaka, 2012). The strength of a correlation can be classified by the 
r value: .00-.19=very weak, .20-.39=weak, .40-.59=moderate, .60-.79=strong, and .80-
1.0=very strong (Royden & Fitzpatrick, 2010). Primary dialysis modality variables (i.e., 
hemodialysis and peritoneal dialysis) were very strongly correlation (r=-1.0). A very 
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strong negative correlation was observed between serum creatinine and glomerular 
filtration rate (GFR) (r=-0.807). Additionally, a strong negative correlation was noted 
between vascular access at first treatment variables CVC and AVF (r=-0.673), strong 
positive correlation between AVF and AVF present (r=0.664), moderate negative 
correlation between yes received pre-dialysis nephrology care and no pre-dialysis 
nephrology care (r=-0.535), moderate positive correlation between yes received pre-
dialysis nephrology care and length greater than 12 months of pre-dialysis nephrology 
care (r=0.598) and strong negative correlation between yes received pre-dialysis 
nephrology care and unknown if received pre-dialysis nephrology care (r=-0.649). 
These correlations are noted in red in table 10 (see appendix 3, pg. 97). Due to the 
numerous collinear relationships among independent variables, a second analysis was 
performed with PROC Reg to observe variance inflation factors (VIF) and tolerance 
limits to prioritize variables (i.e., average lab values, received pre-dialysis care, length of 
pre-dialysis care, and vascular access at 1st treatment) for removal prior to initiating aim 
2 analyses. A VIF greater than 10 and tolerance limit less than 0.1 suggest 
multicollinear relationships between independent variables (Miles, 2014). All 
independent variables were run in the initial PROC Reg model to evaluate VIF and 
tolerance values. The results of the initial PROC Reg analysis evaluating relationships 
between independent variables are presented in table 12. 
Table 12 
Initial Model: Collinearity Results via PROC Reg 
Variable DF Parameter Standard Error t Value Pr > |t| Tolerance 
Variance 
Inflation 
Intercept 1 0.8821 0.6067 1.4500 0.1460 . 0.0000 
Incident Pts 1 0.0022 0.0002 11.1400 <.0001 0.5874 1.7025 
Years in Operation 1 -0.0002 0.0002 -0.9800 0.3285 0.8716 1.1473 
Clinic Size 1 0.0004 0.0003 1.4000 0.1613 0.5854 1.7082 
RN Ratio 1 0.0046 0.0009 5.1600 <.0001 0.8090 1.2361 
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PCT Ratio 1 -0.0037 0.0008 -4.3700 <.0001 0.8845 1.1306 
Chain Associated 1 -0.0014 0.0061 -0.2300 0.8160 0.9411 1.0626 
For-Profit 1 0.0335 0.0075 4.4500 <.0001 0.9622 1.0393 
Received Pre-Dialysis 
Care        
% No B 0.0006 0.0060 0.0900 0.9269 0.0003 3988.4659 
% Yes B -0.0002 0.0060 -0.0400 0.9711 0.0002 6328.6990 
% Unknown B 0.0009 0.0060 0.1400 0.8857 0.0002 5006.1211 
Length of Pre-Dialysis 
Care        
% < 6 Months B 0.0006 0.0001 4.3700 <.0001 0.7883 1.2686 
% 6-12 Months B 0.0003 0.0001 2.3400 0.0195 0.7487 1.3356 
% > 12 Months 0 0.0000 . . . . . 
Vascular Access 1st Tx        
% AVF 1 -0.0009 0.0004 -2.4200 0.0154 0.1273 7.8545 
% AVG 1 -0.0001 0.0005 -0.2400 0.8075 0.4914 2.0349 
% CVC 1 -0.0006 0.0003 -1.7100 0.0867 0.1239 8.0742 
% AVF Present 1 -0.0004 0.0001 -3.1100 0.0019 0.5533 1.8072 
Facility Average Lab 
Values        
Albumin 1 0.0218 0.0061 3.5700 0.0004 0.9027 1.1078 
Serum Creatinine 1 0.0139 0.0026 5.2900 <.0001 0.3133 3.1917 
GFR 1 0.0142 0.0018 8.0400 <.0001 0.3271 3.0575 
Hemoglobin 1 -0.0253 0.0034 -7.5100 <.0001 0.8347 1.1980 
% Received ESA 1 -0.0002 0.0001 -1.1600 0.2447 0.8090 1.2361 
Note: Mos.=Months; CVC=central venous catheter; AVF=arteriovenous fistula; Avg.=average; 
AVG=arteriovenous graft; Tx=treatment; RN=registered nurse; ESA=erythropoietin stimulating agents; 
PCT=patient care tech. 
 
Variables previously identified as concerning for multicollinearity in the pairwise Pearson 
correlation test demonstrated high VIF and tolerance values in the initial PROC Reg 
model (see table 12, values highlighted in red). Multicollinear issues were noted with 
three pre-dialysis nephrology care variables including: %Yes (VIF=6328.6990; 
tolerance=0.0002), %Unknown (VIF=5006.1211; tolerance=0.0002), %No 
(VIF=3988.4659; tolerance=0.0003), two vascular access at first dialysis treatment 
%AVF (VIF=7.8545; tolerance=0.1273) and %CVC (VIF=8.0742; tolerance=0.1239), 
and two facility average lab values variables including: Serum Creatinine (VIF=3.1917; 
tolerance=0.3133) and GFR (VIF=3.0575; tolerance=0.3271). The process of 
elimination of variables with collinear relationships continued with the regeneration of 
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PROC Reg removing collinear variables one at a time. First the decision was made to 
remove % Yes of the received pre-dialysis care variables due to the high VIF and 
tolerance values (see appendix 4, table 13, pg. 99). The VIF and tolerance limits were 
revaluated for impact and then % Unknown was eliminated from the model (see 
appendix 4, table 14, pg. 99). Next, vascular access variables were assessed. Due to 
high VIF and tolerance values % CVC was eliminated and AVF was kept for aim 2 
analysis (see appendix 4, table 15, pg. 100). Finally, facility average lab value variables 
were reviewed. GFR was kept for final analyses and serum creatinine was eliminated 
due to higher VIF and tolerance values. The final PROC reg model with collinear 
variables removed can be found in table 16 (see appendix 4, pg. 101). Additionally, due 
to the lack of variation across the four study years for the facilities percentages of 
incident patient’s dialysis modality, hemodialysis (92%) and peritoneal dialysis (8%) and 
their perfect correlation (r=-1.0), the variables were excluded from final analyses. 
Finally, a year variable indicating the study year (2013-2016) was added to the list of 
independent variables. Thus, six independent variables were removed: 4 with collinear 
relationships and 2 with homogenous data, leaving 22 variables for the regression 
analyses including the study year variable. 
Regression results  
 A repeated-measures multivariable regression model was developed using SAS 
PROC MIXED. The model was run with unstructured covariance parameter estimates 
using the restricted maximum likelihood method and the Kenward-Roger method for 
degrees of freedom due to the use of repeated measures and presence of missing data 
(Brown & Prescott, 2015). In the model, the time frame variable (range = 1-4 years for 
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2013-2016 study years) was the repeated measure, and the unique dialysis facility 
identifier (CCN) was the subject. Results of the initial model with all 22 independent 
variables are displayed in table 17.  
 
Table 17 
Fixed effects model of impact on dialysis facility SRR 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 54.42 <.0001 
Years in Operation 1 6947 1.32 0.2513 
Clinic Size 1 8439 0.34 0.5581 
RN Ratio 1 1.40E+04 22.49 <.0001 
PCT Ratio 1 1.20E+04 11 0.0009 
Chain Associated 1 7628 1.14 0.2858 
For-Profit 1 7040 7.01 0.0081 
Facility Services 2 1 0 1 
Geographic Region 3 7106 73.16 <.0001 
Geographic Location 3 6968 109.5 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 3.65 0.056 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 6.53 0.0106 
% 6-12 Months 1 1.60E+04 18.64 <.0001 
% > 12 Months 1 1.30E+04 70.36 <.0001 
Vascular Access 1st Tx     
% AVF 1 1.90E+04 0 0.9797 
% AVG 1 1.90E+04 0.36 0.55 
% AVF Present 1 1.70E+04 16.7 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 0.49 0.4856 
Hemoglobin 1 1.90E+04 12.03 0.0005 
GFR 1 1.80E+04 17.04 <.0001 
% Received ESA 1 1.60E+04 7.27 0.007 
Year (2013-2016) 3 1.40E+04 2.16 0.0907 
 
To create a parsimonious model with statistically significant predictors of SRR, 
the most desirable covariate structure was determined using backwards elimination of 
independent variables. This procedure involves eliminating a variable whose removal 
results in a statistically insignificant deterioration of the model. Variables are removed 
one at a time and the process is repeated until remaining variables demonstrate a 
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statistically significant p-value resulting in a parsimonious statistical model (Brown & 
Prescott, 2015). The process was initiated by adding all independent variables to the 
model. Variables were then eliminated based on size of the p-value (i.e., descending 
order) until all variables had a statistically significant p-value. Variables were eliminated 
based on p-value in the following order: facility services, % AVF, geographic location, 
years in operation, % AVG, chain associated, % Received ESA, year (2013-2016), 
albumin, received pre-dialysis care % no, length of pre-dialysis care % < 6 months, 
clinic size, and for-profit. Effects of removing these variables can be observed in tables 
18-29 (see appendix 5, pg. 102). The final parsimonious model of dialysis facility and 
incident patient characteristics associated with SRR is displayed in table 30. 
Table 30 
Final Parsimonious Model: Dialysis Facility & Incident Patient Characteristics Associated with SRR 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.10E+04 159 <.0001 
RN Ratio 1 1.40E+04 47.32 <.0001 
PCT Ratio 1 1.20E+04 42.13 <.0001 
Geographic Region 3 7226 82.04 <.0001 
Length of Pre-Dialysis Care     
% 6-12 Months 1 1.80E+04 25.3 <.0001 
% > 12 Months 1 1.40E+04 121.04 <.0001 
% AVF Present 1 1.80E+04 25.4 <.0001 
Facility Average Lab Values     
Hemoglobin 1 1.90E+04 22.88 <.0001 
GFR 1 1.90E+04 18.05 <.0001 
 
 Results of the final model are described further in table 31 with parameter 
estimates, including variable categories for each dialysis facility and incident patient 
characteristic. The number of incident patients, RN ratio, and facility average GFR are 
associated with a higher SRR (e.g., worse than expected if > 1.0). PCT ratio, percent of 
patients with lengths of pre-dialysis nephrology care 6-12 months and greater than 12 
months, percent of patients with an AVF present, and facility average hemoglobin are 
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associated with a lower SRR (e.g., better than expected if < 1.0). Within the geographic 
region variable, facilities located in the Northeast are associated with a higher SRR 
whereas facilities in the West have lower SRRs. 
Table 31 
Parameter estimates for final model 
Fixed Effect Estimate Standard Error DF t Value Pr > |t| 
Intercept 1.0325 0.0298 1.90E+04 34.65 <.0001 
# of Incident Patients 0.0022 0.0002 1.10E+04 12.61 <.0001 
RN Ratio 0.0062 0.0009 1.40E+04 6.88 <.0001 
PCT Ratio -0.0058 0.0009 1.20E+04 -6.49 <.0001 
Geographic Region      
Northeast 0.1206 0.0077 7207 15.67 <.0001 
South 0.0581 0.0062 7240 9.37 <.0001 
Midwest 0.0586 0.0069 7273 8.53 <.0001 
West 0.0000 n/a n/a n/a n/a 
Length of Pre-Dialysis Care      
% 6-12 Months -0.0006 0.0001 1.80E+04 -5.03 <.0001 
% > 12 Months -0.0011 0.0001 1.40E+04 -11 <.0001 
% AVF Present -0.0005 0.0001 1.80E+04 -5.04 <.0001 
Facility Average Lab Values      
Hemoglobin -0.0147 0.0031 1.90E+04 -4.78 <.0001 
GFR 0.0046 0.0011 1.90E+04 4.25 <.0001 
Note: Coefficients of zero due to redundancy are reported “n/a”. 
 
For geographic region, facilities located in the West demonstrated lower SRRs 
compared to facilities in the Northeast based on the estimated means shown in table 
32. 
Table 32 
Estimated Means over time for SRR: Geographic Region 
Fixed Effect Estimate Standard Error DF t Value Pr > |t| 
Geographic Region      
Northeast 1.0522 0.0057 7103 185.39 <.0001 
South 0.9897 0.0033 7141 299.97 <.0001 
Midwest 0.9903 0.0044 7202 223.85 <.0001 
West 0.9316 0.0052 7225 179.59 <.0001 
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Table 33 displays differences in the geographic region variable identifying a statistically 
significant difference (p<.0001) among all regions except for the South and Midwest. 
Dialysis facilities in the Northeast have significantly higher SRRs compared to the West 
(p<.0001) followed by the South (p<.0001) and then Midwest (p<.0001). Facilities in the 
South have higher SRRs than facilities in the West (p<.0001) but lower SRRs than 
facilities in the Midwest (p=0.9996). Finally, facilities in the Midwest has higher SRRs 
than facilities in the West (p<.0001). 
Table 33   
Differences Among Estimated means: Geographic Region   
Region Region Estimate Standard Error DF 
t 
Value Pr > |t| Adjustment Adj P 
Northeast South 0.0625 0.0066 7159 9.45 <.0001 TK <.0001 
Northeast Midwest 0.0620 0.0072 7185 8.56 <.0001 TK <.0001 
Northeast West 0.1206 0.0077 7207 15.67 <.0001 TK <.0001 
South Midwest -0.0006 0.0055 7276 -0.1 0.9202 TK 0.9996 
South West 0.0581 0.0062 7240 9.37 <.0001 TK <.0001 
Midwest West 0.0586 0.0069 7273 8.53 <.0001 TK <.0001 
Note: TK=Tukey-Kramer 
 In summary, the primary and secondary aims resulted in numerous informative 
findings. Variation in means by year for most analyzed dialysis facility and incident 
patient characteristics was minimal (table 7). The majority of dialysis facilities were for-
profit, associated with a dialysis chain, located in the southern geographic region, were 
located in large metropolitan areas, and provided multiple modality services (i.e., ICHD 
and home dialysis). The average facility had been open for 14 years at the start of this 
study (2013), had an average of 19 certified dialysis chairs, approximately 20 incident 
dialysis patients per year, and a 4:1 chair to RN ratio and 3:1 chair to PCT ratio. The 
majority of incident patients received pre-dialysis nephrology care with most receiving 
greater than 12 months of care. Most incident patients initiated hemodialysis as their 
modality type with a CVC for vascular access. The percent of patients with an AVF 
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present upon dialysis initiation declined over the four study years (36% to 34%). 
Average facility-level lab values (albumin, serum creatinine, hemoglobin, and GFR) 
remained relatively stable over the four study years (2013-2016). Patients receiving 
ESA prior to dialysis initiation declined over the study years (14.80% to 12.77%). For 
the secondary aim, several characteristics have favorable associations with SRR 
resulting in lower SRRs. An increase in facility average hemoglobin decreases SRR by 
0.0147, higher PCT ratios decrease SRR by 0.0058, the percent of patients who had 
received greater than 12 months of pre-dialysis nephrology care decreases SRR by 
0.0011, 6-12 months of care decreases SRR by 0.0006 and finally the percentage of 
patients with an AVF present at the initiation of dialysis decreases SRR by 0.0005. 
Conversely, there were characteristics with an unfavorable association with SRR 
resulting in higher SRRs. Higher counts of incident patients increase SRR by 0.0022, 
higher average GFR among facilities increases SRR by 0.0046, higher RN ratios 
increase SRR by 0.0062. Finally, location of dialysis facilities geographically contribute 
to higher SRRs specifically in the Northeast by 0.1206 followed by the Midwest (0.0586) 
and the South (0.0581). 
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Chapter V: Discussion and Conclusions 
 This study of 5,419 dialysis facilities treating an average of 104,768 incident 
patients across the four study years (2013-2016) revealed that dialysis facilities located 
in western region of the United States had significantly lower SRRs compared to 
facilities in the Northeastern region of the United States. Study findings concerning 
staffing demonstrated contrasting relationships among facility personnel with higher RN 
ratios associated with higher SRRs and higher PCT ratios associated with lower SRRs. 
Additionally, the number of incident patients a dialysis facility cared for within a given 
year was associated with higher SRRs. Several modifiable incident patient pre-dialysis 
nephrology care characteristics were found to be associated with lower SRRs including 
higher percentages of patients with an AVF vascular access present at first dialysis 
treatment, higher percentages of patients receiving 6-12 months or greater than twelve 
months of nephrology care prior to dialysis and higher facility average hemoglobin. 
Additionally, higher facility average GFR was associated with higher SRRs.  
RN and PCT Ratios 
 Across the four study years mean staffing ratios for RNs and PCTs declined (RN: 
4-3.85; PCT: 3.57-3.25) meaning fewer chairs per RN and PCT. The cause of this 
decline cannot be defined in this descriptive study, but further research may be done to 
investigate factors influencing increasing and decreasing staff ratios. The addition of a 
nurse could be due to the increase in clinic size (i.e., addition of a certified dialysis 
chair). It was found that 575 facilities included in this study had some change in their 
clinic size over the course of the four-year study period. The majority of clinics (422, 
75%) with noted change in size increased the number of chairs operating in their clinic 
 
 
 62 
therefore, potentially growing the population they serve warranting increased staff. 
Additionally, the increased need for nurses could be due to the increased acuity of the 
patient population or change in patient characteristics however, more research is 
needed to better understand this construct.  
The contrasting association of high RN ratios with high SRRs and high PCT 
ratios with low SRRs illuminates the need to continue to evaluate appropriate staffing 
within dialysis facilities. The increase in PCT ratios associated with a lower SRR 
warrants further investigation into the actual staffing mix. Higher PCT ratios were found 
to decrease SRR by 0.0058 (p<.0001). Perhaps in clinics where there were fewer PCTs 
there were more RNs and an appropriate mix of the two roles together made an impact 
on SRR performance. In contrast, high RN ratios were found to increase SRR by 0.0062 
(p<.0001) meaning the more chairs an RN was responsible for, facility performance on 
the SRR measure declined. Prior research has demonstrated that readmission rates are 
significantly higher in hospitals with lower nurse staffing resulting in higher RN ratios 
(Giuliano, Danesh & Funk, 2016; Kim, Park, Han, Kim & Kim, 2016). These findings 
have been replicated in other healthcare settings and with various patient populations 
as well. A 2016 case study completed in the nursing home setting found that the staffing 
and competence level were suggested to affect hospital readmissions (Glette et al., 
2018). An observational study completed in 2013 found that pediatric patients treated in 
hospitals in which nurses care for fewer patients each are significantly less likely to 
experience readmission illustrating the effectiveness of lower patient-to-nurse ratios 
(Tubbs-Cooley, Cimiotti, Silber, Sloane & Aiken, 2013).  
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In dialysis facilities with greater workloads or an increase in RN ratios (more 
chairs per RN) may be due to vacancy rates of staff within clinics. In the nursing home 
setting, research has demonstrated that licensed nurse retention rate is significantly 
associated with 30-day readmissions (Thomas, Mor, Tyler & Hyer, 2012). Further, 
nursing homes experiencing a 10% increase in their retention had a 0.2% lower 
rehospitalization equating to 2 fewer hospitalizations annually. Prior research in the 
dialysis setting has shown that the turnover of direct patient care staff (RNs, PCTs) 
(22.3%) is much higher than the national hospital nurse turnover rate (8.92%) (Tai & 
Robinson,1998). These rates are potentially higher today in dialysis facilities as these 
rates are from the late 1990’s. More current research still echoes issues with staffing in 
dialysis facilities. An article published in 2015 found that only 57 to 68% of nurses 
working in nephrology settings agreed or strongly agreed that their unit had enough staff 
to handle the workload (Ulrich & Kear, 2015). Additionally, a follow-up study by Ulrich 
and Kear (2018) found additional factors that influence the retention of nurses include 
lack of support and education to safely perform roles and manage care of a highly 
complex patient population and the prevalence of intimidation and bullying by PCTs 
towards nurses new to nephrology practice. Other settings have found similar factors 
influence retention of nurses as well (Sawatzky, Enns & Legare, 2015; Tourangeau, 
Patterson, Saari, Thomson & Cranley, 2017). Further research on vacancy rates and 
the impact of decrease staff on patient outcomes in the dialysis setting is necessary to 
better understand this finding.  
Further descriptive studies on dialysis facility staffing can be done using ESRD 
Facility Annual Survey (CMS-2744). This survey captures the number of employed full 
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and part time staff as well as the number of open positions. The datasets (i.e., DFR) 
used for this study only report the number of staff employed. However, the United 
States Renal Data System (USRDS) has all staffing data reported on the CMS-2744, 
but it has not been further investigated or reported on in the literature.  
In addition to the need for appropriate RN ratios, the role of nurses in outpatient 
dialysis facilities warrants further investigation. The majority of dialysis nurses are 
working in direct patient care solely focused on the clinical aspects of dialysis care with 
minimal opportunity to consider a patient’s care pre and post dialysis, or other factors 
that influence readmission. Therefore, the nurse may not be involved in care and 
treatment that directly impact SRR performance. In contrast, a comprehensive ESRD 
care (CEC) model currently being piloted in the ESRD Seamless Care Organizations 
(ESCOs) includes patient’s care pre and post dialysis, and other factors that influence 
readmission. The CEC model joins dialysis clinics, nephrologists, and other providers 
together to coordinate care for ESRD beneficiaries (CMS, 2018). This model 
encourages dialysis providers to think beyond their traditional roles in care delivery and 
supports them in providing patient-centered care that addresses beneficiaries needs 
both in and outside the dialysis clinic. Evaluation findings of the CEC model revealed 
that while both the ESCO facilities and the comparison group showed improvement over 
time. The combined ESCO SRR exhibited the greatest reduction compared to the 
comparison group in 2016 (The Lewin Group Inc., 2017). Further research is needed to 
investigate staffing mixes, nursing interventions in care coordination and their impact on 
patient outcomes, specifically readmissions. 
Anemia Management 
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A facility’s average hemoglobin g/dL among incident patients initiating dialysis 
reflects anemia management of the patients during their pre-dialysis nephrology care. 
Higher Hemoglobin averages were found to improve SRRs by 0.0147. Hemoglobin 
thresholds for patients with CKD are 12.0 grams per deciliter (g/dL) in female and 
13.0g/dL in men are considered normal (Counts, 2015). The facility average hemoglobin 
among dialysis facilities in this study declined from 9.48 to 9.30 across the four study 
years. Prior research has found that a hemoglobin level greater than or equal to 9.0g/dL 
with ESAs before and after hemodialysis initiation was generally associated with lower 
post-initiation all-cause and cardiovascular mortality (Wetmore et al., 2018). While the 
use of ESAs was not found to be statistically significant in this study, the means of ESA 
use in pre-dialysis nephrology care demonstrated a decline across the four study years 
from 14.80 to 12.77. There are several possible explanations for this decline. First prior 
to 2012 ESA could bill separately for ESA. Then in 2012 ESA was included in the 
federal government’s prospective payment system (PPS) bundle for dialysis care. This 
bundling eliminated ESA as a separately billable medication and brought about a new 
frugality and cost-consciousness in the use of this costly mediation for patients with 
ESRD (Charnow, 2017).  
A second possible reason for the decline in ESA use pre dialysis, is a change in 
practice patterns associated with ESA use after the U.S. Food and Drug Administration 
made a major modification in 2011 to the ESA label stating that ESA should be used at 
the lowest possible dose to avoid a blood transfusion rather than based on the prior 
hemoglobin target range of 10 to 12 g/dL (Singh, 2011). Thus according to the Dialysis 
Outcomes and Practice Patterns Study, from August 2010 to December 2012, the 
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percentage of ESA-treated patients with a hemoglobin concentration less than 10g/dL 
increased from 9% to 20% and those with a hemoglobin concentration greater than 12 
g/dL decreased from 26% to 9% (Fuller, Pisoni, Bieber, Port & Robinson, 2013). In the 
present study facility average hemoglobin appears only mildly affected (i.e., 0.18 
difference from 2013 to 2016) but it influences the SRR.  
Finally, a decline in ESA use may lead to additional complications among 
patients with ESRD not measured in this study that could potentially impact the 
occurrence of readmissions. ESA is used to treat anemia, a common side effect of 
kidney disease experienced by many patients, by stimulating the erythroid progenitor 
cells to form and then release reticulocytes in bone marrow to mature into erythrocytes 
(Counts, 2015). The effects of kidney disease decrease the kidneys ability to make 
endogenous erythropoietin. Without exogenous erythropoietin, via a medication such as 
ESAs, the body may be deprived of the oxygen it needs as bone marrow begins to 
produce fewer red blood cells. Dialysis facilities ability to adequately manage patients’ 
anemia has the potential to minimize risk for cardiac-related events or need for red 
blood cell transfusions that may result in subsequent hospital readmissions. 
Number of Incident Patients 
This study found that the number of incident patients a dialysis facility treated 
was statistically significant in predicting a dialysis facility’s SRR performance. Higher 
counts of incident patients were associated with higher SRRs with an SRR increase of 
0.0022. The average number of incident patients among 5,419 facilities evaluated in the 
study was 19. Therefore, on average 102,961 patients among study facilities could 
negatively impact a facilities performance on the SRR metric. The SRR is the only 
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standardized quality measure that does not exclude the incident population in dialysis 
facility performance calculations. However, it is well-documented in the literature that 
the first ninety days of dialysis treatment, the incident period, possess the greatest risk 
for poor outcomes among incident patients. Over the first ninety days, the risk of 
mortality and hospitalizations are elevated for incident patients (Chan et al., 2011; 
Broers, Cuijpers, van der Sande, Leunissen & Kooman, 2015). In fact, the highest risk 
of mortality for incident patients occurs in the first two weeks of dialysis treatment with 
the risk of death 2.72-fold higher, and the risk of hospitalization 1.95-fold higher when 
compared to patients who survived the first year of chronic dialysis (Chan et al., 2011). 
Additionally, 36% of patients newly diagnosed with ESRD received little or no pre-
dialysis nephrology care with 21% of patients receiving no nephrology care prior to 
ESRD onset (USRDS, 2018). Given the variation in care received prior to dialysis 
initiation incident patients may have varying levels of understanding of their kidney 
disease and how to implement self-management practices. As an incident population in 
a dialysis facility grows, facilities have to redistribute resources that may or may not be 
available to orient new patients to dialysis providing patient education for signs and 
symptoms to be concerned with and when to seek additional medical care. Patients with 
lacking experience may opt to seek emergency medical care at a hospital that results in 
a potential readmission. Further research is needed to better understand patients’ 
utilization of healthcare resources within their first 90 days of dialysis, so that 
interventions can be implemented to reduce unnecessary hospital readmissions and 
better support patient’s transition from CKD management to renal replacement therapy.  
Length of Pre-Dialysis Nephrology Care 
 
 
 68 
 This study found that the percent of incident patients receiving 6-12 months and 
greater than 12 months of pre-dialysis nephrology care increased across the four study 
years and was associated with lower SRRs among dialysis facilities. The association of 
length of pre-dialysis nephrology care with SRR performance suggests the importance 
of access to care prior to initiating renal replacement therapy for treatment of ESRD. 
Current data shows that 36% of all patients newly diagnosed with ESRD received little 
or no pre-dialysis nephrology care with 21% of patients receiving no nephrology care 
(USRDS, 2018). In the current study about half of the incident population were receiving 
pre-dialysis nephrology care in 2016. Given, the percent of patients receiving 6-12 
months of pre-dialysis nephrology care reduced SRR by 0.0006 and patients’ receiving 
greater than 12 months of care reduced SRR by 0.0011 there is a need to educate 
primary care providers of the need for ongoing screening of patients with risk factors for 
CKD so that early referrals to nephrologist can be made. Additionally, so that patients 
can be educated of the need for nephrology care to better manage their kidney disease, 
slow down the advancement of kidney failure, and implement interventions to prepare 
for dialysis if necessary. Besides lack of knowledge of the importance of pre-dialysis 
nephrology care most patients are poorly prepared to begin renal replacement therapy 
often influenced by a lack of health insurance coverage that limits their access to care 
(Mehrotra & Kessler, 2014). Additionally, access to care can be influenced by racial 
disparities in the incidence of ESRD with blacks and Hispanics at higher risk as well as 
low-income Americans. Finally, less than 10% of patients with incident ESRD have had 
counseling by a dietitian, most are unaware of the possibility of home dialysis, pre-
emptive kidney transplantation is rare among newly diagnosed ESRD patients, and a 
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central venous catheter is used as a vascular access for the first dialysis treatment for 
80% of patients first in-center hemodialysis (USRDS, 2018; Kutner, Zhang, Huang & 
Wasse, 2011; Mehrotra, Marsh, Vonesh, Peters & Nissenson, 2005). These 
observations strongly suggest that high burden of ESRD, disparities in the incidence of 
the disease and inadequate preparation for maintenance dialysis stem, in part, from 
challenges in access to care by many vulnerable populations.  
 Access to pre-dialysis nephrology care provides an opportunity for a nephrology 
provider to monitor a patient’s renal function (GFR) over time to determine the most 
appropriate time to start dialysis. This study found that average facility GFR declined 
slightly over the four study years (10.89 to 10.74). However, higher facility average 
GFRs increased SRR by 0.0046. The Initiating Dialysis Early and Late (IDEAL) study 
found there was no detectable benefit of starting dialysis early (Tattersall et al., 2011). 
Additionally, late starts avoid the burden and inconvenience of an early start which has 
been associated with longer time on dialysis and greater resource use (Tattersall et al., 
2011). New guidelines suggest that nephrology providers can wait to initiate dialysis 
until GFR drops below 10 to 12 mL/min. Potentially, starting a patient on dialysis earlier 
exposes them to increased risk factors (e.g., infection, vascular access malfunctions) 
that could be avoided if CKD was managed without renal replacement therapy until 
GFR declined below the recommended guidelines. The delay in initiating dialysis, may 
impact a facility’s performance on SRR if dialysis associated factors cause a patient 
seek emergency medical care and subsequent readmission. Further research is needed 
to investigate patient outcomes based on residual renal function (measured by GFR) at 
the initiation of dialysis. 
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Several studies suggest that pre-dialysis nephrology care is associated with cost-
effectiveness and decreased mortality and morbidity (Black et al., 2010; Kumar, 
Jeganathan & Amruthesh, 2012; Smart & Titus, 2011). Care prior to initiation of dialysis 
not only manages patients through the five stages of kidney failure, but also provides 
ample time to prepare a patient for dialysis (Smart, Dieberg, Ladhani & Titus, 2014). 
Additionally, timely receipt of nephrology care is associated with slower CKD 
progression, lower rates of adverse outcomes, and improved quality of life (MCClellan 
et al., 2009; Smart, Dieberg, Ladhani & Titus, 2014; Diegoli, Silva, Machado & Cruz, 
2015). Further, patients receiving nephrology care prior to dialysis initiation have 
reduced mortality and hospitalizations (Smart & Titus, 2011). Access to pre-dialysis 
nephrology care provides ample time for patients to learn about their disease and feel 
empowered to make decisions for treatment that best suit their lifestyle and desired 
quality of life. Therefore, dialysis facilities with high rates of patients receiving pre-
dialysis nephrology care of at least 6 months potentially have well-prepared patients 
initiating dialysis. The necessary patient education, disease management and 
appropriate interventions needed to correct the treatment course of incident patients 
that may not receive these services prior to ESRD diagnosis and initiation of dialysis 
treatment may tax facilities resources. Further research is needed to further evaluate 
characteristics (e.g., socioeconomic status factors) of patients receiving pre-dialysis 
nephrology care to identify populations that may lack access to care. 
Presence of AVF Vascular Access 
Over the course of the study years, the mean % AVF present among incident 
dialysis patients decreased from 35.67 to 33.65. However, higher percentages of 
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patients initiating dialysis with an AVF present improved or reduced SRR by 0.0005. 
Placement of an AVF is considered the gold standard vascular access for hemodialysis 
(Santoro et al., 2014). AVFs need time to become adequately dilated and develop a 
thick-wall suitable for cannulation, often referred to as maturation. A mature AVF can be 
detected at four weeks, but often takes 8 to 12 weeks before it is ready to be used for 
dialysis treatment (Siddiqui, Ashraff & Carline, 2017). Patients with an AVF in place 
when they initiate dialysis require less exposure to the risks associated with dialyzing 
via a central venous catheter (CVC) which has been associated with increased hospital 
readmissions (Flythe et al., 2016).  
Geographic Region 
 The majority of dialysis facilities included in this study were located in the South 
(43%). The higher rate of facilities located in the South is due to the higher incidence of 
ESRD in that area. Based on a review of the entire prevalent population among all the 
study’s facilities, 41% of the prevalent dialysis population resided in a southern state 
(i.e., MD, WV, VA, DC, NC, SC, GA, FL, TN, AL, MS, AR, OK, LA, TX) (DFR FY2018 
dataset). The smallest number of dialysis facilities included in this study are located in 
the Northeast (15%). Congruently, the smallest percent of prevalent patients (17%) 
reside in a Northeastern states (i.e., ME, NH, VT, MA, RI, CT, NY, NJ, VI, PR, PA, DE). 
Interestingly, this study found that facilities located in the Northeast are associated with 
a higher SRR whereas facilities in the West have lower SRRs. The geographic region 
findings of this study potentially draw attention to the management of dialysis facilities 
by large dialysis organizations. Areas with large market share (i.e., southern states) 
may receive more company attention in the form of resources or interventions to 
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improve outcomes due to increased financial risk associated with pay for performance 
programs. Or perhaps the patient populations are different with more medically complex 
or sicker patients residing in the Northeast compared to the South. Further research is 
needed to investigate the impact of market share distribution as well as patient 
characteristics by geographic region on outcomes such as readmission. 
Limitations 
This study had several limitations. First, this is an observational study at the 
dialysis facility level and reported associations and should not be interpreted as causal 
effects. Second, the only dialysis facilities included in this study were those with at least 
11 index discharges. Of the dialysis facilities included in the last year of this study, fiscal 
year 2016, 84% had at least 11 index discharges. Therefore, these results may only be 
generalizable to larger dialysis facilities with at least 11 index discharges per year. 
Third, the accuracy of the data is dependent upon the original data source from which 
the DFR is produced. Data sources retrieved by the University of Michigan, responsible 
for developing the DFR dataset, is dependent upon dialysis facility data entry. The 
ability to validate facility reported data is not possible due to retrospective nature of this 
study. However, the majority of data sources from which the variables utilized in this 
study are derived (e.g., Medical Evidence Form CMS-2728, ESRD Facility Annual 
Survey CMS-2744, CROWNWeb) are evaluated for completeness and accuracy by 
CMS contractors that may positively influence the validity of the data. 
Implications for Practice 
The results of this study suggest that patients with access to nephrology care 
prior to dialysis initiation may impact a facilities performance on the SRR. Anemia 
 
 
 73 
management and preparation for dialysis with placement of a permanent access (e.g., 
AVF) may improve SRR and should continue to be monitored and evaluated by a 
nephrology provider during CKD care. Pre-dialysis nephrology care provides an 
opportunity for a nephrology provider to best determine when to initiate a patient on 
dialysis based on GFR to avoid unintended consequences of renal replacement 
therapy. Additionally, dialysis facilities should reevaluate their policies and procedures 
around intake of a new patient to dialysis to ensure a smooth transition based on how 
much pre-dialysis nephrology care a patient was known to receive. An intervention such 
as this could allow facilities with high admissions of incident patients to ensure patients 
understand the implications of their disease, signs and symptoms of potential problems, 
and when to seek medical care when away from the dialysis facility. The availability of 
more RNs and PCTs to support these interventions may improve a facility’s 
performance on the SRR. 
Policy Implications 
Dialysis facility RN and PCT ratios are modifiable characteristics that could be re-
evaluated by dialysis organizations to develop staff mixes that support the inclusion of 
care coordination and comprehensive care interventions. A redesign of the current job 
roles staff serve in may allow for the ability to positively impact facility performance on 
the SRR. It’s likely that the financial impact of adjusting staffing and the resources 
needed to facilitate care coordination intervention would need to be projected for nurses 
to be allocated for these kinds of roles within an outpatient dialysis facility. The 
landscape of dialysis roles may continue to evolve as results from the ESCO model 
demonstrate feasible practices that influence patient outcomes.  
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Additional policy implications of this research were identified concerning the 
impact pre-dialysis nephrology care may have on a dialysis facilities performance on the 
SRR. The quantity of incident patients served by unique dialysis facilities may impact a 
facilities ability to overcome the negative effect limited access to nephrology care prior 
to dialysis initiation has on facility performance in readmission prevention. Additionally, 
association of length of pre-dialysis care (i.e., at least 6 months) and having an AVF 
present at dialysis initiation with lower SRRs further highlights the potential need to 
reconsider SRR calculation. Currently, the SRR is calculated using a hierarchical 
logistic model that makes adjustments for the discharging hospital and for patient 
characteristics at the time of discharge including: age, sex, diabetes, BMI, duration of 
ESRD, comorbidities in the preceding year, the presence of a high-risk diagnosis, and 
length of hospital stay (CMS, 2017). In addition to the current covariates, a random 
effect could be incorporated in the SRR calculation to adjust for influential pre-dialysis 
nephrology care characteristics of incident patients including the length of pre-dialysis 
nephrology care, anemia management (i.e., hemoglobin values) and placement of an 
AVF. This adjustment would be similar to the already accepted adjustment for the 
discharging hospitals. The inclusion of a pre-dialysis nephrology care random effect 
would redistribute accountability from just the dialysis facility to include the nephrology 
provider overseeing the patients care during CKD, primary care, or the patient’s lack of 
knowledge that they had CKD prior to ESRD. Finally, while the study design used in this 
study precludes causality, the associations reported between geographic region, 
dialysis facility, incident patient characteristics and SRR could potentially help target 
resources to facilities that are low performers. 
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Research Implications 
 The ultimate purpose of this descriptive study is to generate hypotheses for 
future research investigations. First, based on the results of this study further research 
is needed to understand staffing mixes, nursing interventions in care coordination and 
their impact on patient outcomes, specifically readmissions. Additional research is 
needed on the vacancy rates among RNs and PCTs in dialysis facilities across the 
United States and the impact of those vacancies on facility performance on quality 
metrics such as the SRR. Second, further research is needed to better understand 
utilization of healthcare resources of patients within their first 90 days of dialysis so that 
interventions can be implemented to reduce unnecessary hospital readmissions and 
better support patient’s transition from CKD management to renal replacement therapy. 
Third, further research is needed to evaluate characteristics of patients receiving pre-
dialysis nephrology care to identify populations that may lack access to care. Finally, 
research concerning the impact of geographic region on readmissions is needed to 
evaluate the distribution of market share as well as the clustering effect of incident 
patient characteristics on SRR performance.  
Conclusion 
In summary, this study presents the first facility-level analysis of dialysis facility 
characteristics and incident patient characteristics associated with SRR performance. 
The results show significant differences in geographic region with dialysis facilities 
located in the Northeast having higher SRRs compared to those in the West. Poorly 
performing dialysis facilities in these areas may benefit from a targeted intervention to 
improve care coordination among discharging hospitals, as well as interventions to 
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improve processes within the facility to reduce patients’ risk of readmission. Additionally, 
this study found that the number of incident patients dialyzing in a facility increase SRRs 
while length of pre-dialysis nephrology care of at least 6 months and percent of patients 
with an AVF present at dialysis initiation decreases or improves SRRs. These findings 
illustrate why health care policies must consider how access to care prior to dialysis 
initiation may create an accountability issue targeted at the wrong entity for quality 
measurement and in turn unintentionally inhibit improvement in outcomes of patients. 
Finally, this study found higher RN ratios to be associated with higher SRRs and higher 
PCT ratios to be associated with lower SRRs. These findings illustrate that fewer chairs 
per nurse (i.e., lower RN ratios) may influence patient outcomes and underline the need 
to further investigate staffing mixes and job roles in dialysis facilities to guide future 
interventions. 
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Chapter VI: Concluding Narrative 
 The SRR is a pay for performance quality metric used to evaluate dialysis facility 
performance in readmission prevention among patients with ESRD requiring dialysis 
treatment. A gap in the literature was identified concerning the potential impact of 
additional factors not currently considered in the hierarchical risk adjusted model used 
to calculate SRR. These factors included dialysis facility and patient characteristics. 
Specifically, incident patient characteristics as the SRR is the only metric included in the 
ESRD Quality Incentive Program that does not include the incident population. The 
issue was framed using the Quality Health Outcomes Model due to its inclusion of 
reciprocal relationships with components and theoretically rooted using the Open 
Systems Framework. A descriptive, longitudinal, retrospective study using multivariate 
regression analysis was completed to evaluate the association between dialysis facility 
performance in readmission measured by the SRR, and dialysis facility characteristics 
and incident patient pre-dialysis nephrology care characteristics. Factors found to be 
associated with poor performance on the SRR include high RN ratios, facility average 
GFR, and Northeast geographic location. Factors associated with low SRRs (better 
performance) include high PCT ratio, length of pre-dialysis nephrology care 6-12 
months or greater than 12 months, initiation of dialysis with an AVF, facility average 
hemoglobin, and Western geographic location. These findings reveal the need for 
additional research in variables included in the hierarchical model currently used for risk 
adjustment in the SRR measure calculation that may reflect dialysis facility 
characteristics as well as characteristics of the incident patient population they serve. 
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Appendix 1: Grant Application 
 
Figure 1. Proportion of ESRD Patients Readmitted within 30 days, by treatment 
modality, 2007-2016 
 
Source: USRDS Database; 2018 Annual Report. Abbreviations: ESRD, end stage renal 
disease; HD, hemodialysis; PD, peritoneal dialysis. 
 
Figure 2. Shared Accountability in Readmission Outcomes within Dialysis 
 
Adapted from the Quality Health Outcomes Model (Mitchell, Ferketich & Jennings, 
1998) and Open Systems Theoretical Framework (Katz & Kahn, 1978); variables 
highlighted in yellow are investigated in this proposed study. 
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Table 1 
Concepts and source of data 
Concept Variable Operational Definition 
Variables 
Specifics 
Extracted Variable by Year 
2013 2014 2015 2016 
Incident Adult Patients on Dialysis 
Pre-Dialysis 
Nephrology 
Care 
Incident 
Patients 
# of Incident 
Patients with 
a CMS-2728 
Count nmy1_f nmy2_f nmy3_f nmy4_f 
Recipient of 
Pre-dialysis 
nephrologist 
care (%) 
Patients 
treated for 
CKD prior to 
initiating 
dialysis 
Yes nephyes
y1 
nephyesy2 nephyes
y3 
nephyesy4 
No nephnom
y1_f 
 
nephnomy2
_f 
 
nephnom
y3_f 
 
nephnomy
4_f 
 
Length of 
Pre-dialysis 
nephrologist 
care (%) 
Length of 
CKD 
treatment 
prior to 
initiating 
dialysis 
no care nephnom
y1_f 
nephnomy2
_f 
nephnom
y3_f 
nephnomy
4_f 
<6 
months 
nephy6m
y1_f 
nephy6my2
_f 
nephy6m
y3_f 
nephy6my4
_f 
6-12 
months 
nephy612
my1_f 
nephy612m
y2_f 
nephy61
2my3_f 
nephy612
my4_f 
> 12 
months 
nephy12
my1_f 
nephy12my
2_f 
nephy12
my3_f 
nephy12my
4_f 
Unknown nephunk
missmy1
_f 
nephunkmis
smy2_f 
nephunk
missmy3
_f 
nephunkmi
ssmy4_f 
Incident 
Hemodialysis 
Patients 
# of Incident 
Hemodialysis 
Patients 
Count hemomy1
_f 
hemomy2_f hemomy
3_f 
hemomy4_
f 
Access used 
at first 
outpatient 
dialysis (%) 
Reflects 
management 
during CKD; 
vascular 
access type: 
central 
venous 
catheter 
(CVC), fistula 
or graft at 
dialysis start 
date of 
hemodialysis 
patients 
Fistula mefavfmy
1_f 
mefavfmy2_
f 
mefavfm
y3_f 
mefavfmy4
_f 
Catheter mefcathm
y1_f 
mefcathmy2
_f 
mefcath
my3_f 
mefcathmy
4_f 
Graft mefgraft
my1_f 
mefgraftmy2
_f 
mefgraft
my3_f 
mefgraftmy
4_f 
Arteriovenous 
fistula placed 
(%) 
Gold 
standard 
vascular 
access; 
maturing at 
initiation of 
dialysis 
Yes avfpresen
tmy1_f 
avfpresentm
y2_f 
avfprese
ntmy3_f 
avfpresent
my4_f 
Received 
ESA prior to 
ESRD (%) 
Erythropoieti
n-stimulating 
agent (ESA)  
Yes preepom
y1_f 
preepomy2_
f 
preepom
y3_f 
preepomy4
_f 
Hemoglobin 
g/dL 
Average lab 
values prior 
to start of 
Facility 
Average 
hgmy1_f hgmy2_f hgmy3_f hgmy4_f 
GFR mL/min Facility gfrmy1_f gfrmy2_f gfrmy3_f gfrmy4_f 
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dialysis; 
Glomerular 
filtration rate 
= (GFR)  
Average 
Serum 
creatinine 
mg/dL 
Facility 
Average 
creamy1_
f 
creamy2_f creamy3
_f 
creamy4_f 
Albumin Facility 
Average 
salbmy1_
f 
salbmy2_f salbmy3_
f 
salbmy4_f 
Primary 
Dialysis 
Modality (%) 
Hemodialysis Primary 
modality 
at dialysis 
initiation 
pdmodM
EFHDmy
1_f 
pdmodMEF
HDmy2_f 
pdmodM
EFHDmy
3_f 
pdmodMEF
HDmy4_f 
CAPD/CCPD pdmodM
EFPDmy
1_f 
pdmodMEF
PDmy2_f 
pdmodM
EFPDmy
3_f 
pdmodMEF
PDmy4_f 
Dialysis Facility 
Facility 
characteristi
cs  
Profit status For profit or 
not-for-profit 
For profit 
(1) 
Not for 
profit (0) 
ownery1 ownery2 ownery3 ownery4 
Chain 
Membership 
Chain 
Yes/No 
Yes (1) 
No (0) 
chainy1 chainy2 chainy3 chainy4 
Chain Name Actual 
Name 
(QUAL) 
organy1 organy2 organy3 organy4 
Clinic size Number of 
certified 
stations or 
“chairs” 
 totstas_f 
 
Staffing Staff per 
certified 
stations 
(staffing 
ratios) 
Total 
Staff 
staffy1_f staffy2_f staffy3_f staffy4_f 
Nurses 
per 
dialysis 
chair 
nurseFTy
1_f  
nursePTy
1_f 
nursey1_
f 
nurseFTy2_f 
nursePTy2_f 
nursey2_f 
nurseFTy
3_f 
nursePTy
3_f 
nursey3
_f 
nurseFTy4
_f 
nursePTy4
_f 
nursey4_f 
Patient 
Care 
Techs per 
dialysis 
chair 
ptcareFT
y1_f 
ptcarePT
y1_f 
ptcarey1
_f 
ptcareFTy2_
f 
ptcarePTy2_
f 
ptcarey2_f 
ptcareFT
y3_f 
ptcarePT
y3_f 
ptcarey3
_f 
ptcareFTy4
_f 
ptcarePTy4
_f 
ptcarey4_f 
Length of 
Operation 
Years since 
initial 
Medicare 
certification 
date 
Measure
ment 
Year 
minus 
Variable 
2013 -
FIRST_C
ERTDAT
E 
certdate
y1_f 
2014 -
FIRST_CER
TDATE 
certdatey2_
f 
2015 -
FIRST_C
ERTDAT
E 
certdate
y3_f 
2016 -
FIRST_CE
RTDATE 
certdatey4
_f 
Geography Urban vs. 
Rural (Yan et 
al., 2013) 
1 Large metropolitan counties (situated in 
metropolitan areas with >1 million people) 
2 Medium/small metropolitan counties (in 
metropolitan areas with <1 million people) 
3 Suburban counties (nonmetropolitan counties 
adjacent to metropolitan areas) 
4 Rural counties (nonmetropolitan counties and not 
adjacent to metropolitan areas) 
Northeast Network = 1,2,3,4 
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ESRD 
Geographic 
Network 
Geographic 
Region 
(GeoRegion) 
(Saunders & 
Chin, 2013) 
South Network = 5,6,7,8,13,14 
Midwest Network = 9,10,11,12 
West Network = 15,16,17,18 
Hospital Readmissions 
SRR Readmission
s 
Index 
Discharges 
Facility 
Count 
indexy1_f 
 
indexy2_f 
 
indexy3_f 
 
indexy4_f 
 
Total 
Readmission
s 
Facility 
Count 
readmy1
_f 
 
readmy2_f 
 
readmy3
_f 
 
readmy4_f 
 
Expected 
Readmission
s 
Model 
Result 
srrexpy1_
f 
 
srrexpy2_f 
 
srrexpy3
_f 
 
srrexpy4_f 
 
Standardized 
Readmission 
Ratio 
Facility 
Performa
nce Ratio 
srry1_f srry2_f srry3_f srry4_f 
*Note: Extracted data is at the facility-level; *variables reflect % of patients (i.e., total number of 
patients with submitted CMS-2728 within year of analysis) meeting the criteria; variables 
highlighted in yellow are calculated variables 
 
Table 2 
Urban and Rural Classification using RUCC 2013 and ARF Codes 
RUCC 2013 RUCC Description ARF Code ARF Description 
1 Metro – Counties in metro areas of 
1 million population or more 
1 Large metropolitan 
counties (situated in metropolitan 
areas with >1 million people) 
2 Metro – Counties in metro areas of 
250,000 to 1 million population 
2 Medium/small metropolitan 
counties (in 
metropolitan areas with <1 million 
people) 
3 Metro – Counties in metro areas of 
fewer than 250,000 population 
4 Non-metro – Urban population of 
20,000 or more, adjacent to a 
metro area 
3 Suburban counties 
(nonmetropolitan counties 
adjacent to metropolitan areas) 
6 Non-metro – Urban population of 
2,500 to 19,999, adjacent to a 
metro area 
8 Non-metro – Completely rural or 
less than 2,500 urban population, 
adjacent to a metro area 
5 Non-metro – Urban population of 
20,000 or more, not adjacent to a 
metro area 
4 Rural counties (nonmetropolitan 
counties and not adjacent to 
metropolitan areas) 
7 Non-metro – Urban population of 
2,500 to 19,999, not adjacent to a 
metro area 
9 Non-metro – Completely rural or 
less than 2,500 urban population, 
not adjacent to a metro area 
Source: United States Department of Agriculture, Rural-Urban Continuum Codes, 2013 
https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx  
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Appendix 2: Data Management 
 
Table 3 
State Classification by ESRD Network and Geographic Region 
Geographic Region ESRD Network States and Territories 
Northeast 1, 2, 3, 4 ME, NH, VT, MA, RI, CT, NY, 
NJ, VI, PR, PA, DE 
South 5, 6, 7, 8, 13, 14 MD, WV, VA, DC, NC, SC, GA, 
FL, TN, AL, MS, AR, OK, LA, TX 
Midwest 9, 10, 11, 12 KY, OH, IN, IL, MI, WI, MN, ND, 
SD, MO, IA, NE, KS 
West 15, 16, 17, 18 WY, CO, NM, AZ, UT, NV, MT, 
ID, WA, OR, AK, CA, HI, AS, 
MP, GU, CA 
 
Figure 3. Map of 18 ESRD Networks in the United States 
 
 
 
Table 5 
Missing Data 26 Independent Variables and Outcome Variable 
 No Missing 
Data 
1 Year with 
Missing Data 
2 Years with 
Missing Data 
3 Years with 
Missing Data 
4 Years with 
Missing Data 
# of Facilities 4,089 508 278 193 351 
% 75% 9% 5% 4% 6% 
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Appendix 3: Aim 1 Analysis 
 
Table 9 
Correlation between Dialysis Facility and Incident Patient Characteristics with SRR 
 2013 2014 2015 2016 
 SCC p-
Value 
Assoc. 
with 
SRR 
SCC p-
Value 
Assoc. 
with 
SRR 
SCC p-
Value 
Assoc. 
with 
SRR 
SCC p-
Value 
Assoc. 
with 
SRR 
# Incident Pts 0.1325 <.0001 + 0.1248 <.0001 + 0.1245 <.0001 + 0.0902 <.0001 + 
Clinic Size 0.1006 <.0001 + 0.0789 <.0001 + 0.0791 <.0001 + 0.0582 <.0001 + 
Received Pre-Dialysis Care 
         % Yes -0.1180 <.0001 - -0.0871 <.0001 - -0.1072 <.0001 - -0.0904 <.0001 - 
         % Unknown 0.1065 <.0001 + 0.0865 <.0001 + 0.1000 <.0001 + 0.0744 <.0001 + 
Length of Pre-Dialysis Care 
         % > 12 mos. -0.1194 <.0001 - -0.0887 <.0001 - -0.1096 <.0001 - -0.0775 <.0001 - 
Vascular Access 1st Tx 
         % AVF -0.0652 <.0001 - -0.1031 <.0001 - -0.0984 <.0001 - -0.0859 <.0001 - 
         % CVC 0.0573 <.0001 + 0.0869 <.0001 + 0.0766 <.0001 + 0.0764 <.0001 + 
% AVF Present -0.0786 <.0001 - -0.0892 <.0001 - -0.1134 <.0001 - -0.0780 <.0001 - 
 
Note: SCC=Spearman Correlation Coefficient; Assoc.=association; AVF=arteriovenous fistula; CVC=central venous catheters; Pts=patient
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Table 10 
Correlation between Dialysis Facility and Incident Patient Characteristics with SRR (All Study Variables) 
 
2013 2014 2015 2016 
 SCC p-
Value 
Assoc. 
with SRR 
SCC p-
Value 
Assoc.  
with SRR 
SCC p-
Value 
Assoc.  
with 
SRR 
SCC p-
Value 
Assoc. 
with SRR 
# Incident Pts 0.1325 <.0001 + 0.1248 <.0001 + 0.1245 <.0001 + 0.0902 <.0001 + 
Years in Operation 0.0173 0.2031 + -0.0131 0.3336 - 0.0165 0.2247 + 0.0146 0.2843 + 
Clinic Size 0.1006 <.0001 + 0.0789 <.0001 + 0.0791 <.0001 + 0.0582 <.0001 + 
RN Ratio 0.0232 0.0895 + 0.0155 0.2575 + 0.0022 0.8747 + 0.0130 0.3437 + 
PCT Ratio -0.0845 <.0001 - -0.0796 <.0001 - -0.0664 <.0001 - -0.0159 0.2545 - 
Chain Association 
Yes 
 
0.0180 
 
0.1842 
 
+ 
 
-0.0090 
 
0.5073 
 
- 
 
-0.0143 
 
0.2932 
 
- 
 
0.0001 
 
0.9947 
 
+ 
For Profit 0.0530 <.0001 + 0.0539 <.0001 + 0.0416 0.0022 + 0.0383 0.0048 + 
Facility Services 
ICHD Only 
 
-0.0278 
 
0.0407 
 
- 
 
-0.0495 
 
0.0003 
 
- 
 
-0.0473 
 
0.0005 
 
- 
 
-0.0050 
 
0.7153 
 
- 
ICHD & Home 0.0285 0.0360 + 0.0434 0.0014 + 0.0350 0.0100 + 0.0022 0.8715 + 
Home Only -0.0010 0.9390 - 0.0246 0.0703 + 0.0469 0.0006 + 0.0103 0.4506 + 
Received Pre-Dialysis Care 
% Yes 
 
-0.1180 
 
<.0001 
 
- 
 
-0.0871 
 
<.0001 
 
- 
 
-0.1072 
 
<.0001 
 
- 
 
-0.0904 
 
<.0001 
 
- 
% No 0.0460 0.0007 + 0.0149 0.2728 + 0.0235 0.0842 + 0.0246 0.0703 + 
% Unknown 0.1065 <.0001 + 0.0865 <.0001 + 0.1000 <.0001 + 0.0744 <.0001 + 
Length of Pre-Dialysis Care 
% <6 mos. 
 
-0.0054 
 
0.6927 
 
- 
 
0.0015 
 
0.9125 
 
+ 
 
-0.0123 
 
0.3657 
 
- 
 
-0.0121 
 
0.3723 
 
- 
% 6-12 mos. -0.0268 0.0484 - -0.0132 0.3327 - -0.0201 0.1382 - -0.0254 0.0619 - 
% > 12 mos. -0.1194 <.0001 - -0.0887 <.0001 - -0.1096 <.0001 - -0.0775 <.0001 - 
Vascular Access 1st Tx             
% AVF -0.0652 <.0001 - -0.1031 <.0001 - -0.0984 <.0001 - -0.0859 <.0001 - 
% AVG 0.0257 0.0581 + 0.0216 0.1113 + 0.0052 0.7019 + 0.0093 0.4932 + 
% CVC 0.0573 <.0001 + 0.0869 <.0001 + 0.0766 <.0001 + 0.0764 <.0001 + 
% AVF Present -0.0786 <.0001 - -0.0892 <.0001 - -0.1134 <.0001 - -0.0780 <.0001 - 
Primary Dialysis Modality             
% HD -0.0182 0.1801 - -0.0391 0.0040 - -0.0407 0.0027 - 0.0035 0.7995 + 
% PD 0.0182 0.1801 + 0.0391 0.0040 + 0.0407 0.0027 + -0.0035 0.7995 - 
Facility Average Lab Values             
Albumin -0.0096 0.4978 - -0.0068 0.6337 - -0.0073 0.6066 - -0.0196 0.1698 - 
Serum Creatinine 0.0341 0.0121 + 0.0083 0.5393 + 0.0017 0.8994 + 0.0135 0.3221 + 
Hemoglobin -0.0613 <.0001 - -0.0385 0.0059 - -0.0478 0.0006 - -0.0611 <.0001 - 
GFR 0.0234 0.0854 + 0.0398 0.0034 + 0.0367 0.0069 + 0.0376 0.0056 + 
% Received ESA -0.0576 <.0001 - -0.0524 0.0001 - -0.0486 0.0003 - -0.0430 0.0015 - 
Note: SCC=Spearman Correlation Coefficient; Assoc.=association; ESA=Erythropoietin-stimulating agent; Avg.=average; mos.=months; 
PCT=patient care tech; RN=registered nurse; AVG=arteriovenous graft; ICHD=in-center hemodialysis; PD=peritoneal dialysis; HD=hemodialysis; 
AVF=arteriovenous fistula; CVC=central venous catheters; Pts=patient
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Note: Mos.= Months; Unk=Unknown length of pre-dialysis care; HD=hemodialysis; PD=peritoneal dialysis; AVF=arteriovenous fistula; AVG=arteriovenous graft; CVC=central venous catheter; AVF Pres.=AVF 
Present; Hb=hemoglobin; GFR=glomerular filtration rate; Ck=creatinine; ALB=albumin; Yrs.open=years in operation; Incid. pts=incident patients; RN=registered nurse; PCT=patient care tech
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Appendix 4: Multicollinearity Analysis 
 
Table 13 
Collinearity Results via PROC Reg, eliminating Received Pre-Dialysis Care: % Yes  
Variable DF Parameter Standard Error t Value Pr > |t| Tolerance 
Variance 
Inflation 
Intercept 1 0.8821 0.6067 1.4500 0.1460 . 0.0000 
Incident Pts 1 0.0022 0.0002 11.1400 <.0001 0.5874 1.7025 
Years in Operation 1 -0.0002 0.0002 -0.9800 0.3285 0.8716 1.1473 
Clinic Size 1 0.0004 0.0003 1.4000 0.1613 0.5854 1.7082 
RN Ratio 1 0.0046 0.0009 5.1600 <.0001 0.8090 1.2361 
PCT Ratio 1 -0.0037 0.0008 -4.3700 <.0001 0.8845 1.1306 
Chain Associated 1 -0.0014 0.0061 -0.2300 0.8160 0.9411 1.0626 
For-Profit 1 0.0335 0.0075 4.4500 <.0001 0.9622 1.0393 
Received Pre-Dialysis Care        
% No 1 0.0006 0.0060 0.0900 0.9269 0.0003 3988.4659 
% Unknown 1 0.0009 0.0060 0.1400 0.8857 0.0002 5006.1211 
Length of Pre-Dialysis Care        
% < 6 Months 1 0.0004 0.0060 0.0600 0.9516 0.0004 2578.9453 
% 6-12 Months 1 0.0001 0.0060 0.0200 0.9879 0.0004 2761.8410 
% > 12 Months 1 -0.0002 0.0060 -0.0400 0.9711 0.0002 5055.5017 
Vascular Access 1st Tx        
% AVF 1 -0.0009 0.0004 -2.4200 0.0154 0.1273 7.8545 
% AVG 1 -0.0001 0.0005 -0.2400 0.8075 0.4914 2.0349 
% CVC 1 -0.0006 0.0003 -1.7100 0.0867 0.1239 8.0742 
% AVF Present 1 -0.0004 0.0001 -3.1100 0.0019 0.5533 1.8072 
Facility Average Lab Values        
Albumin 1 0.0218 0.0061 3.5700 0.0004 0.9027 1.1078 
Serum Creatinine 1 0.0139 0.0026 5.2900 <.0001 0.3133 3.1917 
GFR 1 0.0142 0.0018 8.0400 <.0001 0.3271 3.0575 
% Received ESA 1 -0.0253 0.0034 -7.5100 <.0001 0.8347 1.1980 
 
 
Table 14 
Collinearity Results via PROC Reg, eliminating % Received Pre-Dialysis Care: % Unknown 
Variable DF Parameter Standard Error t Value Pr > |t| Tolerance 
Variance 
Inflation 
Intercept 1 0.9688 0.0623 15.5500 <.0001 . 0.0000 
Incident Pts 1 0.0022 0.0002 11.1500 <.0001 0.5874 1.7025 
Years in Operation 1 -0.0002 0.0002 -0.9800 0.3284 0.8716 1.1473 
Clinic Size 1 0.0004 0.0003 1.4000 0.1612 0.5854 1.7082 
RN Ratio 1 0.0046 0.0009 5.1600 <.0001 0.8090 1.2361 
PCT Ratio 1 -0.0037 0.0008 -4.3700 <.0001 0.8845 1.1306 
Chain Associated 1 -0.0014 0.0061 -0.2300 0.8165 0.9412 1.0625 
For-Profit 1 0.0335 0.0075 4.4500 <.0001 0.9622 1.0393 
Received Pre-Dialysis Care        
% No 1 -0.0003 0.0001 -2.7400 0.0061 0.6996 1.4294 
Length of Pre-Dialysis Care        
% < 6 Months 1 -0.0005 0.0001 -3.5900 0.0003 0.7265 1.3765 
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% 6-12 Months 1 -0.0008 0.0001 -5.7700 <.0001 0.7288 1.3722 
% > 12 Months 1 -0.0011 0.0001 -9.5400 <.0001 0.5555 1.8003 
Vascular Access 1st Tx        
% AVF 1 -0.0009 0.0004 -2.4200 0.0154 0.1273 7.8545 
% AVG 1 -0.0001 0.0005 -0.2400 0.8073 0.4914 2.0349 
% CVC 1 -0.0006 0.0003 -1.7100 0.0868 0.1239 8.0741 
% AVF Present 1 -0.0004 0.0001 -3.1100 0.0019 0.5534 1.8071 
Facility Average Lab Values        
Albumin 1 0.0218 0.0061 3.5700 0.0004 0.9028 1.1077 
Serum Creatinine 1 0.0139 0.0026 5.2900 <.0001 0.3133 3.1916 
GFR 1 0.0142 0.0018 8.0400 <.0001 0.3271 3.0573 
% Received ESA 1 -0.0253 0.0034 -7.5100 <.0001 0.8348 1.1979 
 
Table 15 
Collinearity Results via PROC Reg, eliminating Vascular Access 1st Tx: % CVC 
Variable DF Parameter Standard Error t Value Pr > |t| Tolerance 
Variance 
Inflation 
Intercept 1 0.9087 0.0515 17.6600 <.0001 . 0.0000 
Incident Pts 1 0.0022 0.0002 11.1400 <.0001 0.5874 1.7024 
Years in Operation 1 -0.0002 0.0002 -1.0000 0.3187 0.8717 1.1472 
Clinic Size 1 0.0004 0.0003 1.2900 0.1982 0.5882 1.7001 
RN Ratio 1 0.0046 0.0009 5.0900 <.0001 0.8107 1.2335 
PCT Ratio 1 -0.0036 0.0008 -4.3200 <.0001 0.8853 1.1295 
Chain Associated 1 -0.0012 0.0061 -0.2000 0.8402 0.9415 1.0622 
For-Profit 1 0.0335 0.0075 4.4500 <.0001 0.9622 1.0392 
Received Pre-Dialysis Care        
% No 1 -0.0003 0.0001 -2.8200 0.0048 0.7008 1.4269 
Length of Pre-Dialysis Care        
% < 6 Months 1 -0.0005 0.0001 -3.5900 0.0003 0.7265 1.3765 
% 6-12 Months 1 -0.0008 0.0001 -5.7000 <.0001 0.7299 1.3701 
% > 12 Months 1 -0.0011 0.0001 -9.4700 <.0001 0.5566 1.7967 
Vascular Access 1st Tx        
% AVF 1 -0.0004 0.0002 -1.9000 0.0577 0.5321 1.8793 
% AVG 1 0.0004 0.0003 1.3500 0.1759 0.9740 1.0267 
% AVF Present 1 -0.0004 0.0001 -3.2500 0.0011 0.5568 1.7961 
Facility Average Lab Values        
Albumin 1 0.0226 0.0061 3.7100 0.0002 0.9083 1.1009 
Serum Creatinine 1 0.0139 0.0026 5.3000 <.0001 0.3133 3.1916 
GFR 1 0.0142 0.0018 8.0100 <.0001 0.3272 3.0564 
% Received ESA 1 -0.0251 0.0034 -7.4700 <.0001 0.8354 1.1971 
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Table 16 
Final Model Collinear Variables Removed via PROC Reg,  
Variable DF Parameter Standard Error t Value Pr > |t| Tolerance 
Variance 
Inflation 
Intercept 1 1.1035 0.0360 30.6200 <.0001 . 0.0000 
Incident Pts 1 0.0021 0.0002 10.7500 <.0001 0.5910 1.6920 
Years in Operation 1 -0.0002 0.0002 -0.9100 0.3636 0.8720 1.1468 
Clinic Size 1 0.0006 0.0003 1.9500 0.0509 0.5972 1.6744 
RN Ratio 1 0.0045 0.0009 5.0100 <.0001 0.8109 1.2332 
PCT Ratio 1 -0.0038 0.0008 -4.5600 <.0001 0.8871 1.1272 
Chain Associated 1 -0.0014 0.0061 -0.2200 0.8239 0.9415 1.0622 
For-Profit 1 0.0340 0.0075 4.5200 <.0001 0.9624 1.0391 
Received Pre-Dialysis Care        
% No 1 -0.0003 0.0001 -2.6400 0.0083 0.7016 1.4253 
Length of Pre-Dialysis Care        
% < 6 Months 1 -0.0005 0.0001 -3.8400 0.0001 0.7281 1.3734 
% 6-12 Months 1 -0.0008 0.0001 -5.9500 <.0001 0.7315 1.3671 
% > 12 Months 
1 -0.0011 0.0001 
-
10.0400 <.0001 0.5621 1.7791 
Vascular Access 1st Tx        
% AVF 1 -0.0004 0.0002 -2.0900 0.0370 0.5328 1.8769 
% AVG 1 0.0005 0.0003 1.4300 0.1514 0.9742 1.0265 
% AVF Present 1 -0.0004 0.0001 -3.2300 0.0012 0.5568 1.7960 
Facility Average Lab Values        
Albumin 1 0.0244 0.0061 4.0000 <.0001 0.9110 1.0977 
GFR 1 0.0068 0.0011 6.2100 <.0001 0.8528 1.1727 
% Received ESA 1 -0.0284 0.0033 -8.5800 <.0001 0.8645 1.1568 
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Appendix 5: Aim 2 Analysis 
 
Table 18 
Fixed effects model of impact on dialysis facility SRR, Removing Facility Services 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 67.8 <.0001 
Years in Operation 1 6953 1.38 0.2403 
Clinic Size 1 8452 0.39 0.531 
RN Ratio 1 1.40E+04 19.99 <.0001 
PCT Ratio 1 1.20E+04 9.9 0.0017 
Chain Associated 1 7617 1.41 0.2344 
For-Profit 1 7035 7.53 0.0061 
Geographic Region 3 7107 73.23 <.0001 
Geographic Location 3 6969 109.33 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 3.85 0.0499 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 6.02 0.0141 
% 6-12 Months 1 1.50E+04 16.69 <.0001 
% > 12 Months 1 1.30E+04 65.89 <.0001 
Vascular Access 1st Tx     
% AVF 1 1.90E+04 0.01 0.9259 
% AVG 1 1.90E+04 0.24 0.6239 
% AVF Present 1 1.70E+04 18.65 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 1.18 0.277 
Hemoglobin 1 1.90E+04 10.45 0.0012 
GFR 1 1.80E+04 16.75 <.0001 
% Received ESA 1 1.60E+04 7.35 0.0067 
Year (2013-2016) 3 1.40E+04 2.16 0.09 
 
Table 19 
Fixed effects model of impact on dialysis facility SRR, removing % AVF 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 67.83 <.0001 
Years in Operation 1 6951 1.38 0.2399 
Clinic Size 1 8449 0.39 0.5316 
RN Ratio 1 1.40E+04 20 <.0001 
PCT Ratio 1 1.20E+04 9.89 0.0017 
Chain Associated 1 7607 1.41 0.2354 
For-Profit 1 7034 7.53 0.0061 
Geographic Region 3 7089 73.73 <.0001 
Geographic Location 1 1 0 0.9771 
Received Pre-Dialysis Care: % No 1 1.40E+04 3.84 0.05 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 6.02 0.0142 
% 6-12 Months 1 1.50E+04 16.73 <.0001 
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% > 12 Months 1 1.30E+04 66.57 <.0001 
Vascular Access 1st Tx     
% AVG 1 1.90E+04 0.24 0.6218 
% AVF Present 1 1.70E+04 29.73 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 1.17 0.2787 
Hemoglobin 1 1.90E+04 10.51 0.0012 
GFR 1 1.80E+04 16.8 <.0001 
% Received ESA 1 1.60E+04 7.39 0.0066 
Year (2013-2016) 3 1.40E+04 2.17 0.0896 
 
Table 20 
Fixed effects model of impact on dialysis facility SRR, removing Geographic Location 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 74.32 <.0001 
Years in Operation 1 6868 0.51 0.4739 
Clinic Size 1 8490 9.33 0.0023 
RN Ratio 1 1.50E+04 28.32 <.0001 
PCT Ratio 1 1.20E+04 37.83 <.0001 
Chain Associated 1 7548 1.64 0.2003 
For-Profit 1 6959 10.31 0.0013 
Geographic Region 3 7004 79.7 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.24 0.0071 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 9.64 0.0019 
% 6-12 Months 1 1.60E+04 31.51 <.0001 
% > 12 Months 1 1.30E+04 98 <.0001 
Vascular Access 1st Tx     
% AVG 1 1.90E+04 1.22 0.2703 
% AVF Present 1 1.70E+04 34.09 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 5.9 0.0151 
Hemoglobin 1 1.90E+04 26.65 <.0001 
GFR 1 1.80E+04 20.96 <.0001 
% Received ESA 1 1.60E+04 3.36 0.0668 
Year (2013-2016) 3 1.40E+04 2.42 0.0644 
 
Table 21 
Fixed effects model of impact on dialysis facility SRR, removing Years in Operation 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 74.8 <.0001 
Clinic Size 1 8528 8.85 0.0029 
RN Ratio 1 1.40E+04 29.45 <.0001 
PCT Ratio 1 1.20E+04 37.67 <.0001 
Chain Associated 1 7545 1.6 0.2057 
For-Profit 1 6967 10.6 0.0011 
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Geographic Region 3 7004 79.68 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.34 0.0067 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 9.68 0.0019 
% 6-12 Months 1 1.60E+04 31.62 <.0001 
% > 12 Months 1 1.30E+04 98.29 <.0001 
Vascular Access 1st Tx     
% AVG 1 1.90E+04 1.21 0.2717 
% AVF Present 1 1.70E+04 34.13 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 5.92 0.015 
Hemoglobin 1 1.90E+04 26.69 <.0001 
GFR 1 1.80E+04 21.15 <.0001 
% Received ESA 1 1.60E+04 3.36 0.0667 
Year (2013-2016) 3 1.40E+04 2.56 0.0533 
 
Table 22 
Fixed effects model of impact on dialysis facility SRR, removing % AVG 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 74.17 <.0001 
Clinic Size 1 8515 9.13 0.0025 
RN Ratio 1 1.40E+04 29.55 <.0001 
PCT Ratio 1 1.20E+04 38.07 <.0001 
Chain Associated 1 7543 1.68 0.1956 
For-Profit 1 6967 10.59 0.0011 
Geographic Region 3 7003 79.96 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.54 0.006 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 9.62 0.0019 
% 6-12 Months 1 1.60E+04 31.17 <.0001 
% > 12 Months 1 1.30E+04 97.44 <.0001 
% AVF Present 1 1.70E+04 34.99 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 6.29 0.0121 
Hemoglobin 1 1.90E+04 26.78 <.0001 
GFR 1 1.80E+04 20.88 <.0001 
% Received ESA 1 1.60E+04 3.24 0.0718 
Year (2013-2016) 3 1.40E+04 2.55 0.0535 
 
Table 23 
Fixed effects model of impact on dialysis facility SRR, removing Chain Associated 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 72.89 <.0001 
Clinic Size 1 8509 9.62 0.0019 
RN Ratio 1 1.40E+04 31.61 <.0001 
PCT Ratio 1 1.20E+04 39.66 <.0001 
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For-Profit 1 6960 10.02 0.0016 
Geographic Region 3 7007 79.41 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.7 0.0055 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 9.73 0.0018 
% 6-12 Months 1 1.60E+04 30.98 <.0001 
% > 12 Months 1 1.30E+04 97.79 <.0001 
% AVF Present 1 1.70E+04 34.49 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 6.33 0.0119 
Hemoglobin 1 1.90E+04 26.53 <.0001 
GFR 1 1.80E+04 20.66 <.0001 
% Received ESA 1 1.60E+04 3.48 0.062 
Year (2013-2016) 3 1.40E+04 2.51 0.0567 
 
Table 24 
Fixed effects model of impact on dialysis facility SRR, removing % Received ESA 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 73.02 <.0001 
Clinic Size 1 8507 9.35 0.0022 
RN Ratio 1 1.40E+04 32.45 <.0001 
PCT Ratio 1 1.20E+04 39.27 <.0001 
For-Profit 1 6952 10.56 0.0012 
Geographic Region 3 6994 78.9 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.9 0.0049 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 12.94 0.0003 
% 6-12 Months 1 1.50E+04 36.74 <.0001 
% > 12 Months 1 1.30E+04 121.76 <.0001 
% AVF Present 1 1.70E+04 35.04 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 6.07 0.0138 
Hemoglobin 1 1.90E+04 25.64 <.0001 
GFR 1 1.80E+04 21.37 <.0001 
Year (2013-2016) 3 1.40E+04 2.28 0.0768 
 
Table 25 
Fixed effects model of impact on dialysis facility SRR, removing Year 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.30E+04 74.28 <.0001 
Clinic Size 1 8514 9.1 0.0026 
RN Ratio 1 1.40E+04 32.97 <.0001 
PCT Ratio 1 1.20E+04 38.05 <.0001 
For-Profit 1 6953 10.52 0.0012 
Geographic Region 3 6995 78.8 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7 0.0081 
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Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 12.81 0.0003 
% 6-12 Months 1 1.50E+04 36.81 <.0001 
% > 12 Months 1 1.30E+04 122.26 <.0001 
% AVF Present 1 1.70E+04 33.47 <.0001 
Facility Average Lab Values     
Albumin 1 1.80E+04 5.78 0.0162 
Hemoglobin 1 1.90E+04 23.87 <.0001 
GFR 1 1.80E+04 21.5 <.0001 
 
Table 26 
Fixed effects model of impact on dialysis facility SRR, removing Albumin 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.40E+04 77.42 <.0001 
Clinic Size 1 8875 11.56 0.0007 
RN Ratio 1 1.50E+04 33.29 <.0001 
PCT Ratio 1 1.20E+04 40.69 <.0001 
For-Profit 1 7124 10.68 0.0011 
Geographic Region 3 7232 80.4 <.0001 
Received Pre-Dialysis Care: % No 1 1.40E+04 7.54 0.0061 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.50E+04 11.83 0.0006 
% 6-12 Months 1 1.60E+04 36 <.0001 
% > 12 Months 1 1.30E+04 123.17 <.0001 
% AVF Present 1 1.80E+04 26 <.0001 
Facility Average Lab Values     
Hemoglobin 1 1.90E+04 20.49 <.0001 
GFR 1 1.90E+04 18.96 <.0001 
 
Table 27 
Fixed effects model of impact on dialysis facility SRR, removing Received Pre-Dialysis Care: % No 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.40E+04 76.68 <.0001 
Clinic Size 1 8874 11.81 0.0006 
RN Ratio 1 1.50E+04 33.27 <.0001 
PCT Ratio 1 1.20E+04 41.33 <.0001 
For-Profit 1 7125 11.14 0.0009 
Geographic Region 3 7227 79.57 <.0001 
Length of Pre-Dialysis Care     
% < 6 Months 1 1.60E+04 6.73 0.0095 
% 6-12 Months 1 1.70E+04 28.6 <.0001 
% > 12 Months 1 1.40E+04 120.37 <.0001 
% AVF Present 1 1.80E+04 24.15 <.0001 
Facility Average Lab Values     
Hemoglobin 1 1.90E+04 20.35 <.0001 
GFR 1 1.90E+04 20.47 <.0001 
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Table 28 
Fixed effects model of impact on dialysis facility SRR, removing Length of Pre-Dialysis Care % < 6 
Months 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.40E+04 77.63 <.0001 
Clinic Size 1 8870 11.6 0.0007 
RN Ratio 1 1.50E+04 33.76 <.0001 
PCT Ratio 1 1.20E+04 41.63 <.0001 
For-Profit 1 7115 11.87 0.0006 
Geographic Region 3 7218 80.63 <.0001 
Length of Pre-Dialysis Care     
% 6-12 Months 1 1.80E+04 24.09 <.0001 
% > 12 Months 1 1.40E+04 114.39 <.0001 
% AVF Present 1 1.80E+04 25.97 <.0001 
Facility Average Lab Values     
Hemoglobin 1 1.90E+04 21.4 <.0001 
GFR 1 1.90E+04 20.41 <.0001 
 
Table 29 
Fixed effects model of impact on dialysis facility SRR, removing Clinic Size 
Effect Num DF DEN DF F Value Pr > F 
# of Incident Patients 1 1.10E+04 159.13 <.0001 
RN Ratio 1 1.40E+04 44.26 <.0001 
PCT Ratio 1 1.20E+04 39.1 <.0001 
For-Profit 1 7096 10.02 0.0016 
Geographic Region 3 7232 79.11 <.0001 
Length of Pre-Dialysis Care     
% 6-12 Months 1 1.80E+04 24.1 <.0001 
% > 12 Months 1 1.40E+04 115.07 <.0001 
% AVF Present 1 1.80E+04 25.31 <.0001 
Facility Average Lab Values     
Hemoglobin 1 1.90E+04 23.42 <.0001 
GFR 1 1.90E+04 17.22 <.0001 
 
 
